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1 
General introduction and outline of 
the thesis 





Since the middle of the 19th century life expectancy is continuously increasing in 
Western countries 2, resulting in an increasing number of years humans spend 
exposed to the effects of the aging process on their physical and psychological 
well-being. Unfortunately, not all years gained through increasing life expectancy 
are spent in a satisfying health condition. However, there are “successfully” or 
“healthy” aging individuals 3, who seem somehow unchallenged by the aging 
process resulting in healthy longevity. There is evidence that aging is not 
programmed and hence not inevitable 4, 5 and it is supposed to be both under 
environmental as well as genetic control 4. Consequentially, disclosing the secret 
of healthy longevity is of huge importance to learn more about the aging process 
itself and to be able to translate this knowledge into appropriate health 
interventions to increase the healthy life span of “normally” aging individuals. 
 
The Leiden Longevity Study (LLS) was designed to investigate factors associated 
with human familial longevity 6. Dutch Caucasian families were eligible for the 
study if at least two siblings were long-living. The siblings had to fulfil the 
following inclusion criteria: (1) men had to be aged 89 years or older, women had 
to be aged 91 years or older; (2) there had to be at least two living siblings per 
family, who fulfilled the age criterion; (3) the long-living siblings had to have the 
same parents. Middle-aged to elderly offspring of the nonagenarian siblings, who 
are supposed to have a higher susceptibility to become long-lived as well, were 
included along with their spouses as an environmentally and age-matched control 
group. The propensity to become long-lived in the middle-aged to elderly 
offspring as compared to their spouses is marked by beneficial serum levels of 





To investigate whether human familial longevity is also reflected by a lower 
susceptibility to age-related structural brain damage, and more specifically to its 
magnetic resonance imaging (MRI) correlates, was the main purpose of this 
thesis. It should be kept in mind though that to date it is still not known where to 
draw the line between “normal” age-related structural brain changes - if they exist 
at all - and pathologic changes or even disease. Examples for imaging correlates 
of structural brain changes, which often occur “silent” and are thus not inevitably 
linked to an obvious loss of brain function or disease, are brain atrophy, white 
matter hyperintensities, lacunar brain infarcts, microbleeds and enlarged 
perivascular spaces 10. New imaging technologies, such as diffusion tensor 
imaging (DTI) and magnetization transfer imaging (MTI) offer the possibility to 
assess brain tissue integrity non-invasively on the microstructural and 
macromolecular level and thus to study subtle brain damage even before it 
becomes overt on conventional imaging techniques. 
 
Aging of the human brain though cannot be studied without bearing in mind that 
there might be factors with a modifying effect on age-related brain changes, in a 
“negative” or “positive” way, i.e. accelerating or decelerating the “normal” 
course of age-related deterioration of the brain 11. Probably the most well-known 
example is arterial hypertension, which is both genetically and environmentally 
determined and known to be associated with “age-related” brain changes such as 
white matter hyperintensities, lacunar brain infarcts and microbleeds 12-14. 
Prevalence of coronary artery calcification, which is widely accepted as a marker 
of atherosclerosis 15, 16, increases with chronological age and is higher in 
individuals with a history of coronary artery disease as compared to individuals 
without coronary artery disease 17. Although coronary artery calcification has 
been shown to be predictive of future cardiovascular events 18, 19, the underlying 
clinical correlates of arteriosclerotic brain damage are still less obvious. Within 
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the Leiden Longevity Study, we aimed to systematically assess the association of 
coronary artery calcification with vascular brain damage as a potential modifying 
factor of age-related brain pathology in a large study cohort of elderly individuals 
on the macrostructural as well as microstructural level, also taking the spatial 
distribution of brain damage into account. 
 
Hypothesizing that a lower prevalence of age-related brain pathology might be a 
marker of human longevity somehow implies that a higher prevalence of age-
related brain pathology might be a marker of an increased risk of mortality in the 
elderly. Brain atrophy and WML for example have been shown to increase the 
risk of mortality in the general elderly population 20. Cerebral microbleeds (CMB) 
- another imaging correlate of cerebral small vessel disease - are commonly seen 
in healthy elderly individuals 21 and their presence has been shown to be the 
strongest predictor of overall mortality among a range of MRI markers of 
vascular damage in a memory clinic population 22. CMB can be caused by various 
types of small vessel damage of which the two most common types are 
hypertensive vasculopathy and cerebral amyloid angiopathy (CAA), which are 
associated with a different distribution and location of CMB within the brain 23-
29. With regard to the relatively high prevalence of CMB in elderly individuals 
(≈20% in subjects aged 60 to 69 years and ≈40% in subjects aged 80 years and 
older) 28, we aimed to assess the prognostic value of CMB in elderly individuals 
also regarding the different histopathological subtypes. As CMB are particularly 
prevalent in elderly individuals with other vascular risk factors or known history 
of cerebrovascular disease, this study was performed as part of the nested MRI 
substudy of the Prospective Study of Pravastatin in the Elderly at Risk 
(PROSPER), which consists of elderly participants at high risk of or with known 






The Leiden Longevity Study was performed within the scope of the Netherlands 
Consortium for Healthy Ageing (NCHA). The NCHA is an alliance between the 
Leiden University Medical Centre, the Erasmus Medical Centre (Rotterdam), the 
Wageningen University and Research Centre, the University Medical Centre 
Groningen and VU University Medical Centre (Amsterdam) as well as the 
business partners Unilever, Philips, Galápagos, McRoberts, Pfizer and DSM. The 
NCHA was built up to promote the understanding of the aging process and age-
related diseases. It was supported by the Netherlands Genomics Initiative. 
The Leiden Longevity Study was funded by the Innovation Oriented Research 
Program on Genomics (SenterNovem; IGE01014 and IGE5007), Unilever PLC, 
the EU-funded Network of Excellence Lifespan (FP6 036894), the EU funded 
project Switchbox (FP7, Health-F2-2010-259772), and the Netherlands 
Consortium for Healthy Ageing (Netherlands Genomics Initiative/Netherlands 
Organization for scientific research NGI/NWO; 05040202 and 050-060-810). 
The PROSPER study was an investigator initiated study funded by Bristol-Myers 
Squibb. 
 
Outline of the thesis 
 
The first part of the thesis “Phenotyping the brain in human familial longevity 
using MRI” aims to describe the structural phenotype of the brain in familial 
longevity. By investigating age-related changes of the brain in middle-aged to 
elderly offspring with the propensity to become-long-lived as compared to an 
environmentally and age-matched control group, we aimed to learn more about 
the relevance of common age-related brain changes and gave possible starting 
points for future interventional studies to develop strategies for how to translate 
this knowledge into appropriate health interventions to increase the healthy life 
General introduction and outline 
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span of “normally” aging individuals. From the aging point of view, we defined 
the brain structural phenotype in human longevity as brain structure associated 
with “biological aging”, also referred to as senescence. In order to be able to 
differentiate properly between structural brain changes related to “chronological 
aging” and the brain structural phenotype in human longevity, all analyses were 
performed in the whole study population (covering a wide age range) to assess 
the association of brain structure with chronological aging and subsequently in 
offspring of nonagenarian siblings as compared to control subjects to assess the 
association with biological aging. In chapter 2 to 5 age-related brain changes were 
assessed beginning at the macrostructural level (chapter 2 and 3) and ending up 
on the microstructural (chapter 4 and 5). In total, 502 subjects (251 couples) 
participated in this study of which 370 subjects (194 offspring and 176 control 
subjects) underwent an MRI scan of the brain. In chapter 2 automated analysis 
of brain tissue volumes was applied, i.e. whole brain, grey and white matter 
volume as well as the volumes of seven subcortical twin structures (amygdala, 
nucleus accumbens, hippocampus, pallidum, putamen and thalamus) were 
calculated and compared between offspring and control subjects. Secondly, 
imaging correlates of cerebral small vessel disease, such as white matter 
hyperintensities, lacunar brain infarcts and microbleeds, were assessed semi-
quantitatively. Results are described in chapter 3. Chapter 4 deals with 
microstructural brain tissue integrity as measured by diffusion tensor imaging 
(DTI). For image analysis, two relatively new analysis techniques were used: 
Voxel-based morphometry (VBM) and tract based spatial statistics (TBSS). 
Finally, chapter 5 explores differences in macromolecular brain tissue integrity 






The second part of the thesis “Age-related changes of the human brain - 
modifying factors and risk of mortality” gives one example of a potential 
modifying factor on age-related changes of the human brain in general and deals 
with the risk of mortality associated with cerebral microbleeds as a neuroimaging 
correlate of cerebral small vessel disease. In chapter 6 we assessed whether 
coronary artery calcification is associated with age-related vascular brain 
pathology within the Leiden Longevity Study. Chapter 7 describes whether 
cerebral microbleeds are associated with mortality within the PROSPER MRI 
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Background and purpose: 
Atrophy is one of the major age-related changes in the brain. The absence of brain 
atrophy in elderly individuals reflects deceleration in the process of biological 
aging. Moreover, results from human twin studies suggest a large genetic 
influence on the variance of human brain tissue volumes. To investigate the 
association of brain volumes with exceptional longevity, we tested whether 
middle-aged to elderly offspring of nonagenarian siblings have larger brain 
volumes than their spouses. 
 
Methods: 
All subjects were from the Leiden Longevity Study. In this study, middle-aged to 
elderly offspring of nonagenarian siblings, who are predisposed to become long-
lived as well, were contrasted to their spouses. Brain tissue volumes were 
assessed using 3-T MRI. 
 
Results: 
No differences in whole brain, grey matter and white matter volume were found. 
These brain volumes were associated with chronological age in offspring and 
control subjects (all P < 0.001). Left amygdalar volume of the offspring was 
larger (P = 0.03) compared with control subjects (mean volume offspring (cm3) 
(95% confidence interval, CI) = 1.39 (1.36–1.42), mean volume control subjects 
(cm3) (95% CI) = 1.32 (1.29–1.35)). Association of left amygdalar volume with 
familial longevity was particularly pronounced when offspring with the oldest 
long-lived parent were compared with control subjects (P = 0.01). Amygdalar 
volumes were not associated with chronological age in both groups. 
 




Our findings suggest that the observed association of a larger left amygdalar 
volume with familial longevity is not caused by a relative preservation of the left 
amygdala during the course of aging but most likely a result of early development 






Many neurodegenerative changes occur in the brain with increasing 
chronological age. One of the major changes is cerebral atrophy 31, 32. In the last 
two decades, it has become clear that global and local atrophy are associated with 
many neurodegenerative diseases and that progression of atrophy is associated 
with disease progression 33, 34. The absence of brain atrophy is generally assumed 
to be associated with a deceleration in the process of biological aging in elderly 
human individuals 35, 36. 
 
Results from human twin and family studies suggest a large genetic influence on 
the variance of human brain tissue volumes 37. Moreover, about 20–30% of the 
variation in human lifespan is attributable to a heritable component 38, 39. 
However, data on the phenotype of human longevity are scarce and, to our 
knowledge, brain tissue volumes have never been assessed so far in exceptional 
familial longevity. 
 
The Leiden Longevity Study was designed to investigate factors associated with 
human longevity. Offspring of long-lived nonagenarian siblings, who are 
predisposed to become long-lived as well, are contrasted with their spouses 6. The 
propensity to become long-lived in the middle-aged to elderly offspring as 
compared to their spouses is marked by a low incidence of morbidity, beneficial 
serum levels of lipid and thyroid parameters and preservation of insulin 
sensitivity 7-9. 
 
To investigate the association of brain tissue volumes with familial longevity, we 
tested whether individuals enriched for factors of familial longevity have larger 
Brain tissue volumes in longevity 
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brain tissue volumes compared with their partners by means of magnetic 




Characteristics of the study population are shown in Table 2.1. In total, 370 
subjects participated in the study, 194 offspring of long-lived siblings and 176 
control subjects. The mean age was 66 years for the offspring and 65 years for 
the control subjects. Female fraction was lower among the offspring (43%) 
compared with the control subjects (61%) (P = 0.001). No differences in 
handedness and comorbidities were found between the two groups – except for 
the history of diabetes mellitus, which was significantly higher among the control 
subjects. 
 
Table 2.1 Characteristics of the study population 
 Controls (n = 176) Offspring (n = 194) 
Demographics   
   Age (years) 65 (7.4) 66 (6.1) 
   Women* 108 (61) 84 (43) 
   Right-handedness 156 (89) 170 (88) 
Comorbidities   
   Myocardial infarction 5 (3) 3 (2) 
   Stroke 4 (2) 5 (3) 
   Hypertension 43 (24) 40 (21) 
   Diabetes mellitus* 13 (7) 4 (2) 
   Malignancies 17 (10) 13 (7) 
Values are numbers (percentage) for dichotomous variables or means (SD; standard 
deviation) for continuous variables. 




Whole brain, grey matter and white matter volumes, unnormalized as well as 
normalized for skull size, for offspring and control subjects are shown in Table 
2.2. No differences in volumes were found between offspring and control 
subjects. 
 
Table 2.2 Whole brain, grey matter and white matter volumes of offspring and 
control subjects 
Volumes (cm3) Controls (n = 176) Offspring (n = 194) P 
Unnormalized    
  Males (n = 68) (n = 110)  
    Whole brain 1123 (1103-1143) 1149 (1131-1167) 0.23 
    Grey matter 548 (540-557) 564 (556-572) 0.07 
    White matter 575 (562-588) 587 (575-598) 0.45 
  Females (n = 108) (n = 84)  
    Whole brain 1042 (1029-1056) 1040 (1023-1057) 0.86 
    Grey matter 530 (523-536) 529 (521-537) 0.67 
    White matter 513 (504-521) 511 (501-521) 0.98 
Normalized*    
    Whole brain 1407 (1398-1417) 1406 (1397-1415) 0.67 
    Grey matter 705 (699-712) 702 (696-708) 0.34 
    White matter 702 (697-708) 704 (699-710) 0.91 
Values are means (95% CI; 95% confidence interval). P-values are adjusted for 
age and corrected for family relationships among the offspring. * Values are 
means (95% CI; 95% confidence interval) normalized for skull size. P-values are 
additionally adjusted for sex. 
 
To assess regional focal differences in cortical thickness in contrast to overall 
volumetric changes, voxel-based morphometry (VBM) analysis was performed. 
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VBM results did not reveal any significant focal cortical differences between the 
two groups. Whole brain, grey matter and white matter volume were associated 
with chronological age in both offspring and control subjects (Fig. 2.1, all P < 
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Figure 2.1 shows mean nor-
malized whole brain, grey 
matter and white matter 
volumes and their association 
with chronological age sepa-
rately for offspring and con-
trol subjects. P-values are 
adjusted for sex. Associations 
of brain tissue volumes with 
chronological age were not 
statistically significant dif-
ferent between both groups, as 
expressed in the P-value for 
interaction (Pint) (whole brain 
volume: Pint = 0.32, gray 
matter volume: Pint = 0.92, 





Of all subcortical structures left amygdalar volume of the offspring was larger (P 
= 0.03) compared with the control subjects (mean volume offspring (cm3) (95% 
confidence interval, CI) = 1.39 (1.36–1.42), mean volume control subjects (cm3) 
(95% CI) = 1.32 (1.29–1.35)). Figure 2.2 illustrates the output of the automated 




Figure 2.2 The output of the automated segmentation of the right and left amygdala is shown on 
transverse MRI slices exemplary for one study participant. Right and left amygdala are shown in 
white colour. 
 
The association of the left and right amygdalar volume with chronological age is 
shown in Figure 2.3 separately for offspring and control subjects. Both left and 
right amygdalar volume was not associated with chronological age in both 
groups. 





To rule out coincidental volumetric findings, a shape analysis of both left and 
right amygdala was performed for both groups. Figure 2.4 shows the results 
adjusted for multiple comparisons. All vectors on the left amygdala are pointing 
outwards, indicating that offspring have an overall larger left amygdala than 
control subjects. The two blue patches on the left amygdala indicate two highly 
significant areas of local volume difference between the two groups. All vectors 
on the right amygdala are pointing outwards as well. The red colour of the right 
amygdala indicates that, after correction for multiple comparisons, the volume 
difference between the two groups was not statistically significant. With regard 
to the two highly significant areas of local volume difference on the mean surface 
of the left amygdala, a two-dimensional reconstruction of the amygdala using the 
atlas of the human brain from Mai et al. (2008) 40 showed that the observed areas 
Figure 2.3 The association 
of left and right amygdalar 
volume with chronological 
age is shown separately for 
offspring (continuous line) 
and control subjects (bro-
ken line). 
P-values are adjusted for 
sex. Associations of amyg-
dalar volumes with chrono-
logical age were not statis-
tically significant different 
between groups, as ex-
pressed in the P-value for 
interaction (Pint) (left 
amygdalar volume: Pint = 
0.51, right amygdalar 




of local volume difference belong to the ventral part of the nucleus lateralis and 
the lateral part of the nucleus centralis of the left amygdala. 
 
 
Figure 2.4 shows the results of the shape analysis of right and left amygdala of offspring and control 
subjects. The 3D reconstructions represent the mean surface of left and right amygdala of the 
control group. Both amygdalae are shown from lateral. The vectors show the direction of volume 
change, which would be necessary to transform the mean amygdalar surface of the control group 
into the mean amygdalar surface of the group of offspring. The colour bar indicates the statistic 
values. A change of colour from red to blue indicates an increasing statistical significance of the 
difference between both groups. A, anterior; P, posterior; C, caudal; R, rostral. 
 
To further investigate the association of a larger left amygdalar volume with 
exceptional familial longevity, offspring were dichotomized based on the mean 
age (96.8 years) of their long-lived parent and compared with the control subjects 
separately. Offspring, whose long-lived parent was aged > 96.8 years, had a 
significantly larger (P = 0.01) left amygdalar volume compared with the control 
subjects (Table 2.3). By contrast, no difference of left amygdalar volume was 
found between offspring, whose long-lived parent was aged ≤ 96.8 years and 
control subjects. 
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Table 2.3 Amygdalar volumes of offspring and control subjects 
 Controls 
(n = 176) 




(n = 89) P 
Group 2 
(n = 105) P 
   Left 1.32 (1.29-1.35) 1.37 (1.33-1.41) 0.32 1.41 (1.37-1.45) 0.01 
   Right 1.30 (1.27-1.33) 1.33 (1.28-1.37) 0.95 1.36 (1.32-1.40) 0.17 
Values represent unnormalized means (95% CI; 95% confidence interval). P-
values, indicating the statistical significance of the difference in mean amygdalar 
volumes between offspring group 1 and control subjects and offspring group 2 
and control subjects respectively, are adjusted for age and sex and corrected for 
family relationships among the offspring. Bold indicates significance value. 
Group 1: offspring whose long-lived parent was aged ≤ 96.8 years. 




Our study shows that middle-aged to elderly individuals, who are enriched for 
familial factors of longevity, have larger left amygdalar volumes compared with 
control subjects, whereas no association of the left amygdalar volume with 
chronological age was found in both groups within an age range of 46–85 years. 
Familial longevity was not associated with larger whole brain, grey and white 
matter volumes in middle-aged to elderly individuals. 
 
In contrast to the association of amygdalar volume with the propensity of familial 
longevity, no difference in association with chronological age was found in both 
groups. These findings may suggest that the observed increased left amygdalar 
volume is not caused by a relative preservation of the left amygdala during the 




familial trait. This hypothesis is further supported by the fact that the association 
of left amygdalar volume with familial longevity was particularly pronounced 
when offspring with the oldest long-lived parent were compared with the control 
subjects. Studies on the genetic influence on the variance of amygdalar volumes 
in middle-aged to elderly individuals are scarce. In a human twin study, a high 
heritability of 0.80 for the left and 0.50 for the right amygdalar volume has been 
described 41. This supports our hypothesis that offspring of long-lived siblings 
display larger left amygdalar volumes owing to a genetic predisposition. 
Structural and functional changes within the human amygdalae have been shown 
to be associated with several neurodegenerative and neuropsychiatric diseases, 
such as Alzheimer’s disease 42, post-traumatic stress disorder, schizophrenia, 
major depression disorder 43, 44, bipolar disorder 45, social anxiety disorder 46, or 
Parkinson’s disease 47. A recent study showed that patients with Alzheimer’s 
disease and elderly schizophrenia patients have significantly lower left amygdalar 
volumes compared with healthy elderly controls 48. Moreover, symptoms in 
schizophrenia patients correlated with a relatively lower left amygdala compared 
with the right amygdala 48. Further research is needed to disentangle the 
consequences of a larger left amygdalar volume in human familial longevity. 
Our data do not show any association of amygdalar volume with chronological 
age in any of the groups. During the last two decades, age-related changes of the 
amygdalar volume have been assessed in several studies of the aging brain, but 
results remain controversial. Whereas some studies found an age-related decline 
of the amygdalar volume 49-52, others found a relative preservation of the 
amygdalae compared with other brain structures 53-55. Data about side differences 
in amygdalar volume measurements are sparse. The mentioned studies either did 
not differentiate between right and left amygdalar volumes 49 or did not find any 
side difference 50, 52 with one exception: showing smaller right amygdalar 
volumes in healthy right-handed elderly individuals compared with young study 
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participants 51. However, most of the mentioned studies have assessed the 
association of amygdalar volume with age cross-sectionally with a wide age 
range of study subjects, rather small numbers of study participants and using 
different analysis techniques. All these facts complicate a proper comparison of 
study results. 
 
Our study showed a strong inverse association of whole brain, grey matter and 
white matter volume with chronological age. These findings are in line with 
findings from other studies of the aging brain 31, 32, 55. There are only a few studies, 
which have found an age-related volume loss of total white matter volume 32, 56, 
57. However, a regional age-related white matter volume loss has consistently 
been described in literature 31, 54. No differences in whole brain, grey matter and 
white matter volume were found between offspring and control subjects. Human 
twin and family studies on the influence of genetic factors on the variation of 
human brain tissue volumes have indicated a high heritability for total brain, grey 
matter and white matter volume 37. However, to our knowledge, there have been 
no studies so far exploring a possible association of these brain volumes with 
human familial longevity. Our findings suggest that the phenotype of familial 
human longevity is not reflected by larger volumes of whole brain, grey matter 
or white matter. As our study participants were relatively young concerning age-
related volume loss of brain tissues, further studies are needed to investigate 
whether differences possibly emerge at a higher mean age. 
 
One of the strengths of our study is the unique study design of comparing middle-
aged to elderly individuals, who are enriched for familial factors of longevity, to 
their spouses. This allowed us to gain more insight into the relevance of age-
related changes of the human brain, which can be frequently detected on MRI 




the influence of the socioeconomic and geographical background was relatively 
low, which makes the two groups highly comparable in terms of environmental 
factors. Third, our inclusion algorithm resulted in a large study sample, which 
allows us to assess even small differences between the two groups. The fact that 
the study subjects were relatively young concerning age-related changes of the 
human brain is a limitation of this study. As differences between the two groups 
are likely to be rather small, a higher mean age of the study groups would 
probably facilitate the detection of possible differences. Second, our analyses 
were adjusted for the most common confounding parameters of brain tissue 
volume analysis: age and sex. It cannot be excluded that cardiovascular risk 
factors, such as diastolic blood pressure, diabetes or smoking, small vessel 
disease or physical activity, may (partly) have an additional effect 58, 59. Also, 
amygdalar activity and therefore amygdalar volumes might have been affected 
by differences in emotional aspects and personality factors between groups 60-63. 
Finally, as an automated segmentation method was used to segment subcortical 
structures, deviations may be found when compared to manual segmentation as 
the golden standard. 
 
In conclusion, this is the first study to our knowledge comparing age-related 
changes of brain tissue volumes between middle-aged to elderly individuals with 
a familial predisposition to become long-lived and their spouses. Our findings 
indicate that, at a mean age of about 66 years, the left amygdalar volume is larger 
in offspring of nonagenarians compared with their spouses. The lack of an 
association of amygdalar volume with chronological age and the fact that the 
association of left amygdalar volume with familial longevity was particularly 
pronounced when offspring with the oldest long-lived parent were selected, 
suggest that the observed volume difference is determined by genetic 
predisposition. The association of a lower amygdalar volume with several 
Brain tissue volumes in longevity 
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neurodegenerative and neuropsychiatric diseases suggests that middle-aged to 
elderly individuals, who are enriched for factors of familial longevity, may be 





Participants were included from the LLS, which has been described in more detail 
elsewhere 6. The LLS was set up to investigate parameters and pathways 
associated with and contributing to the longevity phenotype. In short, 421 Dutch 
Caucasian families were enrolled in the study between 2002 and 2006 based on 
the following inclusion criteria: (i) there were at least two living siblings per 
family, who fulfilled the age criteria and were willing to participate; (ii) men had 
to be aged ≥ 89 years and women had to be aged ≥ 91 years; and (iii) the sib pairs 
had to have the same parents. Additionally, offspring of these long-lived siblings 
were included. A survival benefit of approximately 30% has been shown in three 
generations of LLS families. Hence, the longevity phenotype is inherited in the 
LLS families. Partners of the offspring of the long-lived siblings were included 
as a control group as they are likely to have the same age, socioeconomic and 
geographical background. The current study focused on the investigation of brain 
imaging markers of the longevity phenotype. 
For the current study, participants were recruited from the offspring of the long-
lived siblings and their spouses. In total, 502 subjects participated in the study of 
which 370 subjects (194 offspring and 176 controls) underwent an MRI scan of 
the brain. Subjects were included as couples, however, some offspring (n = 57) 
and controls (n = 75) were excluded because of contraindications for MRI. 
Ninety-three of 194 offspring were related to at least one other offspring, who 





All imaging was performed on a whole body MR system operating at a field 
strength of 3T (Philips Medical Systems, Best, The Netherlands). Three-
dimensional T1-weighted images were acquired from all study participants with 
the following imaging parameters: 
TR = 9.7 ms, TE = 4.6 ms, FA = 8°, FOV = 224 x 177 x 168 mm, resulting in a 
nominal voxel size of 1.17 x·1.17 x·1.4 mm, covering the entire brain with no 
gap between slices, acquisition time was approximately 5 min. 
 
MRI analysis 
All MRI scans were analysed using different tools of FMRIB Software Library 
(FSL; 64, 65). 
Whole brain volume, grey matter and white matter volumes were calculated using 
the FSL-tool Structural Image Evaluation, using Normalization, of Atrophy 
(SIENAX; 66, 67). SIENAX starts by extracting brain and skull images from the 
single whole-head input data 68. The brain image is then affine-registered to 
MNI152 space 69, 70, using the skull image to determine the registration scaling. 
This is primarily performed to obtain the volumetric scaling factor, to be used as 
a normalization for head size. Next, tissue-type segmentation with partial volume 
estimation is performed 71 to calculate total volume of brain tissue, including 
separate estimates of volumes of grey matter and white matter. 
To assess regional focal differences in cortical thickness in contrast to overall 
volumetric changes, FSL-VBM, a voxel-based morphometry style analysis 54, 72, 
was performed. First, structural images were brain-extracted using Brain 
Extraction Tool 68. Next, tissue-type segmentation was carried out using 
FMRIB’s Automated Segmentation Tool (FAST4; 71). The resulting gray matter 
partial volume images were aligned to MNI152 standard space using the affine 
registration tool FMRIB’s Linear Image Registration Tool 69, 70, followed by 
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nonlinear registration using FMRIB’s Nonlinear Image Registration Tool 73, 74. 
The resulting images were averaged to create a study-specific template, to which 
the native grey matter images were then nonlinearly reregistered. To correct for 
local expansion or contraction, the registered partial volume images were 
modulated by dividing by the Jacobian of the warp field. The modulated 
segmented images were smoothed with an isotropic Gaussian kernel with a sigma 
of 3 mm. Finally, voxel wise general linear model (GLM) was applied using 
permutation-based nonparametric testing, correcting for multiple comparisons 
across space. 
FMRIB’s Integrated Registration and Segmentation Tool (FIRST) was used to 
determine the volume of the brain stem and the volumes of the subcortical twin 
structures nucleus accumbens, amygdala, caudate nucleus, hippocampus, 
pallidum, putamen and thalamus. FIRST starts by registering all images to 
MNI152 templates. Second it fits models for all different structures (meshes) to 
the images and finally applies boundary correction for the volumetric output 75. 
The shape/appearance models used in FIRST are constructed from manually 
segmented images provided by the Center for Morphometric Analysis, MGH, 
Boston. Most (if not all) manual volumetric methods for amygdala segmentation 
used coronal plane to delineate amygdala boundary. All amygdalar volumes 
measures below -3 or above 3 standard deviations were excluded from statistical 
analysis. 
By means of FIRST vertex analysis, local changes of vertex locations of 
subcortical structures were investigated. This type of analysis does not require 
boundary correction to be performed, as it works directly with the vertex 
coordinates (in continuous space) of the underlying meshes. Vertex analysis is 
performed by carrying out a multivariate test on the three-dimensional 
coordinates of corresponding vertices. Each vertex is analysed independently, 




discovery rate or surface- based cluster corrections. The changes in position 
(global rotation and translation) between different subjects were removed by rigid 
alignment of the individual meshes. Subsequently, a multivariate F-test was 
performed for each vertex separately using the multivariate GLM 75. 
 
Statistical analysis 
If not otherwise stated, data are presented as mean with standard deviation (SD) 
(characteristics of the study population) or mean with 95% CI to assess 
differences between groups. Differences in sex, handedness and comorbidities 
between offspring and control subjects were calculated using Chi-square tests. 
Differences in age were tested using independent samples t-tests. Brain tissue 
volumes were normally distributed. Analyses of differences between offspring 
and control subjects were assessed using a logistic regression model. Robust 
standard errors were calculated to correct for family relationships among the 
offspring. All analyses of differences between offspring and control subjects were 
adjusted for age and sex. A linear regression model was used to assess the 
association of the various brain tissue volume measurements with chronological 
age separately for offspring and control subjects. To test whether there was a 
significant difference in the association of a certain brain tissue volume with age 
between offspring and control subjects univariate general linear modelling was 
used. The P-value for interaction (Pint) estimates the statistical significance of 
the difference of the association of the brain tissue volumes with chronological 
age between the two groups. For statistical analyses, SPSS software for windows 
(version 17.0.1; SPSS, Chicago, IL, USA) was used. Robust standard errors were 
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Background and purpose: 
On MRI, cerebral white matter lesions, lacunar infarcts, and cerebral microbleeds 
are common imaging correlates of cerebral small vessel damage in apparently 
healthy elderly individuals. We investigated whether middle-aged to elderly 
offspring of nonagenarian siblings, who are predisposed to become long-lived as 
well, have a lower prevalence of white matter lesions, lacunar infarcts, and 
cerebral microbleeds than control subjects. 
 
Methods: 
All subjects were from the Leiden Longevity Study. In this study, middle-aged to 
elderly offspring of nonagenarian siblings, who are predisposed to become long-
lived as well, were contrasted to their spouses. Cerebral small vessel disease was 
assessed using 3-T MRI. 
 
Results: 
Offspring were less likely to have severe periventricular frontal caps (odds ratio 
(OR), 0.3; 95% confidence interval (CI), 0.1–1.1; P trend = 0.01) and severe 
periventricular bands (OR, 0.4; 95% CI, 0.2–0.8; P trend = 0.02). Moreover, 
offspring were less likely to have frontal (OR, 0.4; 95% CI, 0.2–0.9; P trend = 
0.05), parietal (OR, 0.4; 95% CI, 0.1–0.9; P trend = 0.001), temporal (OR, 0.3; 
95% CI, 0.1–0.8; P trend = 0.004), and occipital subcortical white matter lesions 
(OR, 0.3; 95% CI, 0.1–0.6; P trend = 0.001). Prevalence of lacunar infarcts also 
was lower in offspring (OR, 0.3; 95% CI, 0.1–1.1; P = 0.07). Prevalence of 
microbleeds was not significantly different in offspring and control subjects. 
 
 




Exceptional familial longevity is associated with a lower susceptibility to white 






Cerebral small vessel disease is common in old age 76. On MRI, cerebral white 
matter lesions (WML), lacunar infarcts, and cerebral microbleeds (CMB) 
frequently can be detected in apparently healthy elderly individuals as imaging 
correlates of cerebral small vessel damage 13, 77, 78. Presence of WML, lacunar 
infarcts, and CMB in the elderly has been shown to be associated with 
cerebrovascular disease, such as ischemic stroke or cerebral haemorrhage 79-81, 
progression of these diseases 82, and increased mortality risk 20, 79, 83. For WML, 
a high degree of heritability has been reported 84, 85. The relative absence of WML, 
lacunar infarcts, and CMB thus may reflect a decelerated process of biological 
aging and serve as a marker for the phenotype of human longevity. 
 
The Leiden Longevity Study was designed to investigate factors associated with 
human longevity. Offspring of long-lived nonagenarian siblings, who are 
predisposed to become long-lived as well, were contrasted to their spouses 6. The 
propensity to become long-lived in the middle-aged to elderly offspring as 
compared with their spouses is marked by a low incidence of morbidity, 
beneficial serum levels of lipid and thyroid parameters, preservation of insulin 
sensitivity, and a lower prevalence of myocardial infarction, hypertension, 
diabetes mellitus, and use of cardiovascular medication 7-9, 86. 
 
To study whether the phenotype of human familial longevity also is reflected by 
a lower susceptibility to cerebral small vessel disease, we investigated whether 
middle-aged to elderly individuals, who are enriched for familial factors of 
longevity, have a lower WML load and a lower amount of lacunar infarcts and 
CMB compared with their spouses using MRI.  






Subjects were included from the Leiden Longevity Study, which has been 
described in more detail elsewhere 6. In short, 421 Dutch white families were 
enrolled in the study between 2002 and 2006 based on the following inclusion 
criteria: (1) there were at least 2 living siblings per family who fulfilled the age 
criteria and were willing to participate; (2) men had to be aged ≥ 89 years and 
women had to be aged ≥ 91 years; and (3) the sib pairs had to have the same 
parents. Additionally, offspring of these long-lived siblings were included 
because they have a 35% lower mortality rate compared with the general 
population. Their partners, who share the same socioeconomic and geographic 
background, were enrolled as the age-matched control group 6. 
For the current study, subjects were recruited from the offspring of the long-lived 
siblings and their spouses. In total, 502 subjects (251 couples) participated in the 
current study, of which 370 subjects (194 offspring and 176 control subjects) 
underwent an MRI scan of the brain. Some offspring (n=57) and control subjects 
(n=75) were excluded because of contraindications for MRI. Of 194 offspring, 
93 were related to at least one other offspring who participated in the current 
study. The Medical Ethical Committee of the Leiden University Medical Centre 
approved the study, and written informed consent was obtained from all subjects. 
The study was performed in accordance with institutional guidelines. 
 
MRI acquisition 
All imaging was performed on a whole-body magnetic resonance system 
operating at a field strength of 3-T (Philips Medical Systems). Three-dimensional 
(3-D) T1-weighted, T2-weighted, fluid attenuated inversion recovery (FLAIR), 




3-D T1-Weighted Images 
Repetition time was 9.7 ms, time to echo was 4.6 ms, flip angle was 8°, and field 
of view was 224×177×168 mm, resulting in a nominal voxel size of 
1.17×1.17×1.4 mm, covering the entire brain and with no gap between slices. 
Acquisition time was ≈5 minutes. 
T2-Weighted Images 
Repetition time was 4200 ms, time to echo was 80 ms, flip angle was 90°, field 
of view was 224×180×144 mm, matrix size was 448×320, and 40 transverse 
slices covered the entire brain, with a slice thickness of 3.6 mm with no gap 
between slices. 
FLAIR 
Repetition time was 11 000 ms, time to echo was 125 ms, flip angle was 90°, field 
of view was 220×176×137 mm, matrix size was 320×240, and 25 transverse 
slices covered the entire brains, with a slice thickness of 5 mm with no gap 
between slices. 
T2*-Weighted Images 
Repetition time was 45 ms, time to echo was 31 ms, flip angle was 13°, and field 
of view was 250×175×112 mm.  
Because of technical problems, T2-weighted and FLAIR images were available 
for 368 subjects (194 offspring and 174 control subjects) and T2*-weighted 
images were available for 285 subjects (149 offspring and 136 control subjects). 
 
MRI analysis 
Cerebral white matter lesions and lacunar infarcts 
MRI scans were visualized using the freely available software Medical Image 
Processing, Analysis, and Visualization (MIPAV). WML and lacunar infarcts 
were analysed blinded to subject identity, age, sex, and affiliation to the study 
group. WML were defined as areas within the cerebral white matter with 
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increased signal intensity on both FLAIR and T2-weighted images and without 
mass effect. WML were rated according to a slightly modified version of the 
semi-quantitative rating scale of Scheltens et al. 1. Periventricular and subcortical 
WML were rated separately, and semi-quantitative regional scores were obtained 
by taking the size, amount, and anatomical distribution of the high signal 
abnormalities into account (Figure 3.1). For each of these two categories, more 
detailed scores for further 
anatomical subdivisions are 
provided. 
Presence and number of 
lacunar infarcts were 
assessed on FLAIR, T2-
weighted, and 3-D T1-
weighted images. Lacunar 
infarcts were defined as 
parenchymal defects within 
the cerebral white matter not extending into the cortical grey matter, with a signal 
intensity centrally corresponding to that of cerebrospinal fluid on all three 
imaging sequences, surrounded by a rim of increased signal intensity on FLAIR. 
Diameter of lacunar infarcts was defined to be > 2 mm. To distinguish lacunar 
infarcts from normal dilated perivascular spaces (Virchow-Robin-Spaces), 
lesions within the lower one-third of the corpus striatum of the basal ganglia and 
a diameter of < 2 mm were excluded 87. 
 
Cerebral microbleeds 
MRI scans were visualized using the freely available software MIPAV. CMB 
were analysed blinded to subject identity, age, sex, and affiliation to the study 
group. CMB were defined as focal areas of signal void on T2-weighted images, 
Figure 3.1 Slightly modified version of the semi-quantitative 




which increased in size on T2*-weighted images (blooming effect). In this way, 
CMB were distinguished from vascular flow voids. Symmetric hypointensities in 
the basal ganglia, likely to represent calcifications or nonhaemorrhagic iron 
deposits, were disregarded 25. For each subject, the number and localization 
(corticosubcortical junction, deep white matter, and basal ganglia) were recorded. 
 
Statistical analysis 
If not otherwise stated, data are presented as mean with SD (characteristics of the 
study population) or odds ratios (ORs) with 95% CI to assess differences among 
groups. Differences in sex, history of hypertension, diabetes mellitus, smoking, 
myocardial infarction, and stroke between offspring and control subjects were 
calculated using χ2 tests. Differences in age, body mass index, and levels of 
cholesterol were tested using independent samples t tests. To assess differences 
in WML load, presence of lacunar infarcts, and CMB between offspring and 
control subjects, a logistic regression model was applied. Study participants with 
no lesions were set as a reference group and ORs were calculated for all other 
groups relative to the reference group. The P value for trend indicates whether 
the OR increases with increasing degree of severity of a certain type of lesion. 
All analyses of differences between offspring and control subjects were adjusted 
for age and sex (Model 1) and additionally for cardiovascular risk factors (history 
of hypertension, diabetes mellitus, myocardial infarction, stroke and smoking, 
body mass index, and cholesterol; Model 2). Robust standard errors were 
calculated to correct for family relationships among the offspring. Significance 
thresholds were set at P < 0.05. For statistical analysis, SPSS software for 
windows (version 17.0.1; SPSS) was used. Robust standard errors were 
calculated with Stata statistical software for windows (version 10; Stata). 
 
 





Characteristics of the study population are shown in Table 3.1. In total, 368 
subjects participated in the study (194 offspring of long-lived siblings and 174 
control subjects). The mean age was 66 years for offspring and 65 years for 
control subjects, with a significantly lower female percentage of 43% among 
offspring compared with 61% among control subjects (P = 0.001). All analyses 
of differences between offspring and control subjects were, therefore, adjusted 
for sex. Moreover, significantly more control subjects had a history of diabetes 
mellitus compared with the offspring. No differences were found concerning 
other cardiovascular risk factors. Five offspring (3%) and four control subjects 
(3%) had a history of clinical stroke. 
 
Table 3.1 Characteristics of the study population 
 Offspring (n = 194) Controls (n = 174) 
Demographics   
   Age (years) 66 (6) 65 (7) 
   Women* 84 (43) 106 (61) 
Cardiovascular risk factors   
   Hypertension 40 (23) 43 (28) 
   Diabetes mellitus* 4 (2) 13 (8) 
   Myocardial infarction 3 (2) 5 (3) 
   Stroke 5 (3) 4 (3) 
   Total cholesterol (mmol/L) 5.65 (1.26) 5.71 (1.17) 
   Smoking 20 (10) 24 (14) 
   Body mass index (kg/m2) 25.2 (3.3) 25.5 (3.4) 
Values are numbers (percentage) for dichotomous variables or means (standard 




Different degrees of severity of periventricular and subcortical WML are shown 
in Figure 3.2. Prevalence of periventricular WML in offspring and control 
subjects is shown in Table 3.2. Offspring of long-lived siblings were less likely 
to have severe frontal caps compared with control subjects (OR, 0.3; 95% CI, 
0.1–1.1; P trend = 0.01), which remained after additional adjustment for 
cardiovascular risk factors (P trend=0.03). Moreover, offspring of long-lived 
siblings were less likely to have severe periventricular bands (OR, 0.4; 95% CI, 
0.2–0.8; P trend = 0.02). After additional adjustment for cardiovascular risk 
factors, effect estimates remained similar, whereas significance attenuated (P 
trend = 0.06). Prevalence of occipital caps was not significantly different between 
the 2 groups. 
 
 
Figure 3.2 Different degrees of peri-
ventricular and subcortical white matter 
lesions (WML) on magnetic resonance 
imaging (MRI): (A) subject without WML, 
(B) subject with a severe degree of frontal 
and occipital caps and periventricular 
bands (score 2/2/2), and (C) subject with a 
severe degree of subcortical WML (score 
6/6/6/6). 
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Table 3.2 Periventricular white matter lesion load in offspring and control subjects 
 Offspring 
(n = 194) 
Controls 
(n = 174) 
OR (95% CI) 
P 
OR (95% CI) 
P 
Model 1 Model 2 
Frontal caps       
   0 10 (5) 5 (3) 1.0 (ref)  1.0 (ref)  
   1 140 (72) 109 (63) 0.6 (0.2-1.8) 0.35 0.6 (0.2-1.8) 0.37 
   2 44 (23) 60 (35) 0.3 (0.1-1.1) 0.07 0.3 (0.1-1.1) 0.09 
   P trend    0.01  0.03 
Bands       
   0 40 (21) 24 (14) 1.0 (ref)  1.0 (ref)  
   1 134 (69) 122 (70) 0.6 (0.4-1.1) 0.14 0.6 (0.3-1.1) 0.14 
   2 20 (10) 28 (16) 0.4 (0.2-0.8) 0.02 0.4 (0.2-1.0) 0.06 
   P trend    0.02  0.06 
Occipital caps       
   0 78 (40) 59 (34) 1.0 (ref)  1.0 (ref)  
   1 93 (48) 86 (49) 0.8 (0.5-1.3) 0.40 0.7 (0.4-1.2) 0.25 
   2 23 (12) 29 (17) 0.6 (0.3-1.1) 0.10 0.5 (0.2-1.1) 0.11 
   P trend    0.11  0.09 
Total score       
   0 6 (3) 2 (1) 1.0 (ref)  1.0 (ref)  
   1 (1-3) 145 (75) 113 (65) 0.4 (0.1-2.0) 0.22 0.4 (0.1-2.0) 0.21 
   2 (4-6) 43 (22) 59 (34) 0.2 (0.04-1.1) 0.05 0.2 (0.04-1.1) 0.05 
   P trend    0.01  0.01 
Values are numbers (percentage) or OR (odds ratios) (95% CI, confidence interval). P 
values are adjusted for age and sex and corrected for family relationships among the 
offspring (Model 1), and are additionally adjusted for cardiovascular risk factors (Model 
2). 
 
Prevalence of subcortical WML for offspring and control subjects is shown in 




0.4; 95% CI, 0.2–0.9; P trend = 0.05), parietal (OR, 0.4; 95% CI, 0.1–0.9; P trend 
= 0.001), temporal (OR, 0.3; 95% CI, 0.1–0.8; P trend = 0.004), and occipital 
subcortical WML (OR, 0.3; 95% CI, 0.1–0.6; P trend = 0.001). All associations 
remained similar after additional adjustment for cardiovascular risk factors. 
Prevalence of lacunar infarcts was low, with a nonsignificant difference between 
offspring (2%) and control subjects (5%) (OR, 0.3; 95% CI, 0.1–1.1; Table 3.4). 
Prevalence of CMB was similar in offspring (14%) and control subjects (13%) 
(OR, 1.0; 95% CI, 0.5–2.1). Additional adjustment for cardiovascular risk factors 
did not alter the results.  
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Table 3.3 Subcortical white matter lesion load of offspring and control subjects 
 Offspring 
(n = 194) 
Controls 
(n = 174) 
OR (95% CI) 
P 
OR (95% CI) 
P 
Model 1 Model 2 
Frontal       
   0 37 (19) 25 (14) 1.0 (ref)  1.0 (ref)  
   1 (1-3) 132 (68) 111 (64) 0.8 (0.5-1.5) 0.60 0.9 (0.5-1.7) 0.76 
   2 (4-6) 25 (13) 38 (22) 0.4 (0.2-0.9) 0.05 0.5 (0.2-1.1) 0.13 
   P trend    0.05  0.13 
Parietal       
   0 95 (49) 52 (30) 1.0 (ref)  1.0 (ref)  
   1 (1-3) 87 (45) 106 (61) 0.4 (0.3-0.7) < 0.001 0.4 (0.3-0.7) 0.001 
   2 (4-6) 12 (6) 16 (9) 0.4 (0.1-0.9) 0.03 0.4 (0.2-1.1) 0.07 
   P trend    0.001  0.004 
Temporal       
   0 100 (52) 67 (39) 1.0 (ref)  1.0 (ref)  
   1 (1-3) 85 (44) 92 (53) 0.5 (0.4-0.9) 0.01 0.5 (0.3-0.9) 0.01 
   2 (4-6) 9 (5) 15 (9) 0.3 (0.1-0.8) 0.02 0.4 (0.1-1.1) 0.08 
   P trend    0.004  0.01 
Occipital       
   0 128 (66) 96 (55) 1.0 (ref)  1.0 (ref)  
   1 (1-3) 52 (27) 48 (28) 0.7 (0.4-1.1) 0.16 0.9 (0.5-1.5) 0.70 
   2 (4-6) 14 (7) 30 (17) 0.3 (0.1-0.6) 0.001 0.3 (0.1-0.7) 0.01 
   P trend    0.001  0.02 
Total score       
   0 31 (16) 18 (10)     
   1 (1-6) 109 (56) 83 (48) 0.8 (0.4-1.5) 0.48 0.9 (0.4-1.8) 0.74 
   2 (7-12) 35 (18) 41 (24) 0.5 (0.2-1.0) 0.06 0.5 (0.2-1.1) 0.09 
   3 (13-24) 19 (10) 32 (18) 0.3 (0.1-0.7) 0.01 0.4 (0.1-1.0) 0.07 
   P trend    0.001  0.01 
CI indicates confidence interval; OR, odds ratio. P values are adjusted for age and sex and corrected 
for family relationships among the offspring (Model 1), and are additionally adjusted for 






Table 3.4 Lacunar infarcts and cerebral microbleeds of offspring and control subjects 
 Offspring 
(n = 194) 
Controls 
(n = 174) 
OR (95% CI) 
P 
OR (95% CI) 
P 
Model 1 Model 2 
Lacunar 
infarcts 
      
   Absent 190 (97.9) 166 (95.4) 1.0 (ref)  1.0 (ref)  
   Present 4 (2.1) 8 (4.6) 0.3 (0.1-1.1) 0.07 0.5 (0.1-1.8) 0.27 
CMB       
   Absent 128 (86) 118 (87) 1.0 (ref)  1.0 (ref)  
   Present 21 (14) 18 (13) 1.0 (0.5-2.1) 0.92 1.2 (0.5-2.6) 0.73 
CI indicates confidence interval; OR, odds ratio. Values are numbers (percentage) or OR (95% CI) 
adjusted for age and sex and corrected for family relationships among the offspring (Model 1), and 




This study shows that middle-aged to elderly individuals who have a familial 
higher susceptibility to become long-lived have a lower periventricular as well as 
subcortical WML load and a lower prevalence of lacunar infarcts compared with 
control subjects independent of their cardiovascular risk profile. In contrast, 
prevalence of CMB was similar in both groups. 
 
Our findings suggest that exceptional familial longevity is associated with a lower 
susceptibility to WML as well as lacunar infarcts. Studies on the genetic 
determinants of cerebral WML have reported a high degree of heritability in 
younger study subjects with a low prevalence of cerebral WML, suggesting 
WML to be an excellent genetic marker of brain aging 84, 85. The Notch3 gene, 
apolipoprotein E (APO E) gene, and the angiotensin-converting enzyme (ACE) 
gene are examples of genes that have been identified to be associated with the 
formation of WML 88-90. However, it is not known, so far, whether the genetic 
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difference in the susceptibility to the formation of WML is because of genetic 
differences in the aging process itself or because of a genetically determined 
different susceptibility to cardiovascular damage or both 84. In our study, 
additional adjustment for cardiovascular risk factors did not change the 
association of exceptional familial longevity with a lower prevalence of 
periventricular as well as subcortical WML, suggesting a genetically determined 
lower susceptibility of the offspring to the formation of cerebral WML in the 
course of aging, regardless of their cardiovascular risk profile. Several genes have 
been identified to be associated with the presence of lacunar infarcts 90-93. In this 
study, a lower prevalence of lacunar infarcts was associated with familial 
longevity, barely reaching statistical significance. Reported prevalence of lacunar 
infarcts in the general elderly population ranges from 5% to ≈30% 94-96. Thus, 
overall prevalence in our study population (3%) was relatively low. Because the 
prevalence of lacunar infarcts increases with age, with a low prevalence at an age 
of ≈60 years, our study subjects were, with a mean age of 66 years, relatively 
young for the detection of lacunar infarcts 97. A higher mean age of the study 
population could have increased the detected difference in prevalence of lacunar 
infarcts between both groups. Additional adjustment for cardiovascular risk 
factors did not alter the results, suggesting that offspring of long-lived siblings 
have a lower susceptibility to the formation of lacunar infarcts during the aging 
process compared with control subjects, regardless of their cardiovascular risk 
profile. However, the low prevalence of lacunar infarcts hampers a proper 
interpretation of the data. 
In the Leiden Longevity Study, the propensity to become long-lived in the 
middle-aged to elderly offspring as compared with control subjects is marked by 
a low incidence of morbidity, beneficial serum levels of lipid and thyroid 
parameters, preservation of insulin sensitivity, and a lower prevalence of 




medication 7-9, 86. In the current substudy, offspring also showed a lower 
prevalence of hypertension, diabetes mellitus, and myocardial infarction, with the 
difference only reaching statistical significance for history of diabetes mellitus. 
This is most likely because of the lower number of study participants as compared 
with the original cohort. 
Exceptional familial longevity was not associated with a lower prevalence of 
CMB. The age-specific prevalence of CMB has been reported to increase from 
≈7% in individuals aged 45 to 50 years to ≈36% in individuals aged ≥ 80 years 
in the population-based Rotterdam Scan Study 98. The APOE ε4 gene was 
associated with the presence of strictly lobar CMB 98, 99. Overall, prevalence of 
CMB in our study confirms the age-stratified prevalence of CMB reported in the 
Rotterdam Scan Study (mean age of our study population, 66 years; age range, 
46–85 years) 98. Prevalence of CMB was similar in offspring and control subjects, 
suggesting that the propensity of familial longevity is not associated with a lower 
susceptibility to CMB. 
One of the strengths of our study is the unique study design of comparing middle-
aged to elderly individuals, who have a genetically determined higher 
susceptibility to become long-lived, with control subjects. This will allow us to 
gain more insight in the relevance of age-related changes of the human brain, 
which can be frequently detected on MRI scans in the general aging population. 
Second, by including the partners of the offspring of the long-lived siblings as the 
control group, the two groups were highly comparable concerning their 
socioeconomic and geographic background. Finally, our inclusion algorithm 
resulted in a large study sample, which allows us to investigate even small 
differences between the two groups. 
The fact that the study subjects were relatively young concerning age-related 
changes of the human brain belongs to the limitations of this study. Because 
differences between the two groups are likely to be small, a higher mean age of 
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the study groups would probably facilitate the detection of possible differences. 
Second, some individual categories did not reach statistical significance or did 
not remain significant after full adjustment for cardiovascular risk factors. The 
described phenomenon mostly appeared in categories with a low number of study 
participants, which have relatively low statistical power and were usually the 
most severe categories. However, a clear dose–response could be observed for 
almost all abnormalities in both models, which was expressed in decreasing ORs 
with increasing severity of the lesions. This also was indicated by the P value for 
trend. 
 
To the best of our knowledge, this is the first study to compare imaging markers 
of cerebral small vessel disease between elderly individuals with a familial 
predisposition to become long-lived and their partners. Our findings indicate that 
at a mean age of 66 years, exceptional familial longevity is associated with a 
lower susceptibility to WML and lacunar infarcts but not CMB. Because this 
association did not change after additional adjustment for cardiovascular risk 
factors, it is likely that differences in the susceptibility to WML and lacunar 
infarcts between offspring of long-lived siblings and control subjects are because 
of genetic differences in the process of aging and are not driven by a genetically 
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Background and purpose: 
Brain tissue integrity is highly heritable, and its decline is a common phenomenon 
of aging. This study aimed to determine whether the phenotype of familial 
longevity is marked by a relative preservation of brain tissue microstructure. 
 
Methods: 
Participants were enrolled in the Leiden Longevity Study. In total, 185 middle-
aged to elderly offspring of nonagenarian siblings, who were enriched for familial 
factors of longevity, were contrasted with 171 environment- and age-matched 




Voxel-wise analysis revealed widespread age-related decrease of white matter 
fractional anisotropy and increases of axial, radial, and mean diffusivity (all P < 
0.003). Offspring showed higher mean white matter fractional anisotropy (mean 
(standard error): offspring, 0.3232 (0.0009); controls, 0.3212 (0.0009); P = 0.04) 
compared to control subjects independent of cardiovascular risk factors. When 
differences in white matter diffusion parameters between offspring and control 
subjects were assessed voxel-wise, offspring showed higher white matter 
fractional anisotropy and lower white matter radial diffusivity predominantly in 
the callosal genu and body (both P < 0.003). With the effect of chronological age 
on white matter microstructure taken into account, offspring can be considered 
4.5 years “biologically younger” compared to control subjects with regard to 
white matter integrity. 
 




Both middle-aged to elderly offspring of nonagenarian siblings and control 
subjects show common age-related decline of white matter integrity, but it is less 
marked in the callosal genu and body in the offspring. This corresponds to a 







Loss of brain tissue integrity is common in old age and can be assessed 
noninvasively by using magnetic resonance diffusion tensor imaging (DTI) 100, 
101. DTI contrast is based on diffusion of water protons, which is characterized by 
random (isotropic) motion in regions with no constraints. Diffusion within tissues 
is usually not random; it is instead restricted (anisotropic) by physiological 
boundaries such as fibre components, which results in different diffusion rates 
dependent on the diffusion direction 102. Commonly, the rate of diffusion, or 
diffusivity, is described in three perpendicular directions per voxel. For white 
matter, diffusivity along the axons is assumed to be the largest and is 
characterized by the eigenvalue L1 (axial diffusivity, AxD). The rate of diffusion 
perpendicular to the axial diffusivity is called radial diffusivity (RD) and is 
described by the mean of the eigenvalues L2 and L3 103. Fractional anisotropy 
(FA) is a summary measure comprising the three-dimensional (3D) diffusion 
information and reflecting the orientational coherence of the underlying tissue. In 
contrast, mean diffusivity (MD) is a measure of diffusion magnitude within a 
certain voxel without orientational information, representing the mean of the 
three eigenvalues L1, L2, and L3 104. Due to its microstructural organization, 
white matter is by far the most frequently assessed brain tissue in DTI studies of 
the aging brain, particularly because DTI allows the detection of even subtle 
white matter damage that is not visible using conventional magnetic resonance 
imaging (MRI) and therefore yields additional insight into age-related 
neurodegenerative brain changes. 
 
Studies on age-related changes of white matter integrity consistently report a 
decline of white matter FA 100, 105. For axial, radial, and mean diffusivity, different 
patterns of age-related changes have been reported for different brain regions 106, 
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107. Moreover, an anterior–posterior gradient of age-related loss of white matter 
integrity has been described 101, 108, 109, which is also reflected by the age-related 
deterioration of predominantly frontally located functional networks 108. This 
anterior–posterior gradient is assumed to be based on late-myelinating regions, 
such as the white matter of the frontal lobes or the genu of the corpus callosum, 
being composed of thinner axons with a higher vulnerability to age-related 
myelin breakdown as compared with early myelinating brain regions 110-112. 
According to human twin studies, white matter integrity, even in old age, is under 
significant genetic control 113, 114. Thus, a relative preservation of brain tissue 
integrity against age-related neurodegeneration might reflect a decelerated 
process of biological aging that is at least partly genetically determined. 
 
The Leiden Longevity Study was designed to investigate factors associated with 
human longevity. Offspring of long-lived nonagenarian siblings, who are 
predisposed to become long-lived as well, were contrasted with their spouses 6. 
In middle-aged to elderly offspring, the propensity to become long-lived is 
marked by beneficial serum levels of lipid and thyroid parameters; preserved 
insulin sensitivity; lower prevalence of myocardial infarction, hypertension, 
diabetes mellitus, and use of cardiovascular medication; and lower prevalence of 
cerebral white matter lesions (WML) as well as lacunar infarcts 7-9, 86, 115. 
 
The primary aim of the current study was to study whether the phenotype of 
familial longevity is reflected by a relative preservation of brain tissue 
microstructural integrity. Additionally, changes of brain tissue integrity with 
chronological age were assessed in the whole study population to enable proper 









Subjects were participants in the Leiden Longevity Study, which has been 
described in more detail elsewhere 6. In short, 421 Dutch Caucasian families were 
enrolled in the study between 2002 and 2006 based on the following inclusion 
criteria: (1) there were at least two living siblings per family, who fulfilled the 
age criteria and were willing to participate, (2) men had to be aged ≥ 89 years and 
women had to be aged ≥ 91 years, and (3) the sib pairs had to have the same 
parents. Additionally, offspring of these long-lived siblings were included 
because they have a 35% lower mortality rate compared with the general 
population. Their partners, who shared the same socioeconomic and geographical 
background, were enrolled as an environment and age-matched control group 6, 
86. All couples in which the partner met the inclusion criteria for the offspring 
group were excluded from the study. 
The current study focused on the offspring of the long-lived siblings and their 
spouses. In total, 502 subjects (251 couples) participated in the study, 370 of 
whom underwent an MRI scan of the brain (194 offspring, 176 control subjects). 
Some offspring (n = 57) and control subjects (n = 75) were excluded due to 
contraindications for MRI. Contraindications were determined according to the 
standardized MRI patient questionnaire of the Leiden University Medical Centre. 
Excluded subjects were comparable to included subjects with regard to age, sex, 
and comorbidities. Ninety-three of 194 offspring were related to at least one other 
offspring in the study. The Medical Ethical Committee of the Leiden University 
Medical Centre approved the study, and written informed consent was obtained 
from all subjects. 
 
 




Imaging was performed on a whole body magnetic resonance system operating 
at a field strength of 3T (Philips Medical Systems, Best, The Netherlands). 3D 
T1-weighted images were acquired with the following imaging parameters: 
repetition time (TR) = 9.7 milliseconds, echo time (TE) = 4.6 milliseconds, FA = 
8°, field of view (FOV) = 224 x 177 x 168 mm, resulting in a nominal voxel size 
of 1.17 x 1.17 x 1.4 mm, covering the entire brain with no gap between slices; 
acquisition time was approximately 5 minutes. The imaging parameters for DTI 
images were as follows: TR = 9,592 milliseconds, TE = 56 milliseconds, FA = 
90°, FOV = 220 x 220 x 128 mm, matrix size 112 x 110, 64 transverse slices to 
cover the entire brain with a slice thickness of 2 mm with no gap between slices, 
32 measurement directions, and b-value = 1,000. 
Due to technical problems, DTI images were only available for 360 subjects (189 
offspring, 171 control subjects). Four subjects (four offspring) were excluded 
from data analyses because of severe scan artefacts. 
 
MRI analysis 
All MRI analyses were performed with blinding to the subject status (offspring 
vs control subjects). For analysis of DTI scans, different tools of the Functional 




The individual raw diffusion tensor images were pre-processed to create 
individual FA, L1, L2, L3, and MD images using FDT (FMRIB’s Diffusion 
Toolbox) tools 116-118. The original images were corrected for effects of head 
movement and eddy currents in the gradient coils, which induce stretches and 




reference volume. A diffusion tensor model was fitted to the eddy current-
corrected images to create individual FA, L1, L2, L3, and MD images. 
 
Global quantification of brain tissue FA, AxD, RD, and MD 
3D T1-weighted images were skull stripped using BET (Brain Extraction Tool) 
68 and subsequently segmented using FAST (FMRIB’s automated segmentation 
tool)71 and FIRST (FMRIB’s integrated registration and segmentation tool) 75, 
resulting in individual brain masks for white matter, grey matter, and the 
following subcortical grey matter structures: amygdala, caudate nucleus, 
hippocampus, nucleus accumbens, pallidum, putamen, and thalamus. All 
segmented brain structures were aligned into common space using the linear 
registration tool FLIRT (FMRIB’s linear image registration tool) 69, 70. Mean FA, 
AxD, RD, and MD values were calculated for the regions of interest. 
 
Voxel-based analysis of white matter FA, AxD, RD, and MD 
Voxel-wise statistical analysis of white matter FA data was performed using 
Tract-Based Spatial Statistics (TBSS) 119. All subjects’ FA data were aligned into 
common space using the nonlinear registration tool FNIRT (FMRIB’s nonlinear 
image registration tool) 73, 74. A mean FA image was created and thinned to create 
a mean FA skeleton representing the centres of all tracts common to the group. 
Each subject’s aligned FA data were projected onto this skeleton. Likewise, 
individual AxD, RD, and MD images were prepared for voxel-wise statistics. 
 
Statistical analysis 
If not otherwise stated, data are presented as mean with standard deviation or 
mean with standard error (SE) to assess differences between groups. Differences 
in sex, handedness, and comorbidities between offspring and control subjects 
were calculated using chi-square tests. Differences in age were tested using 
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independent samples t tests. A linear regression model was used to assess the 
association of diffusion parameters with chronological age in the whole study 
population adjusted for sex and affiliation with the offspring or control group. 
For all analyses concerning the association between diffusion parameters and 
chronological age, Bonferroni post hoc test was used to correct for multiple 
comparisons. Allowing for n = 36 comparisons, the significance threshold was 
set at p < 0.0014. Differences in diffusion parameters between offspring and 
control subjects were assessed using a linear regression model, adjusted for age 
and sex. To take the potential effect of cardiovascular comorbidities and risk 
factors on brain tissue DTI parameters into account, the following models were 
additionally used in the regression analysis. First, all study subjects with a history 
of stroke or myocardial infarction were excluded from analysis, which was 
adjusted for age and sex. Second, the analysis was additionally adjusted for 
history of diabetes mellitus, and third it was additionally adjusted for history of 
hypertension. Robust standard errors were calculated to correct for family 
relationships among the offspring. Statistical tests concerning the association 
between diffusion parameters and biological age were not Bonferroni corrected. 
For statistical analyses, Statistical Package for the Social Sciences (SPSS) 
software for Windows (version 20.0.1; IBM, Armonk, NY) was used. Robust 
standard errors were calculated with Stata software for Windows (version 12; 
StataCorp, College Station, TX). 
For voxel-wise statistics, the FSL randomize tool was used to perform 
permutation-based nonparametric testing (n = 5,000 permutations). Threshold-
free cluster enhancement (TFCE) was applied to correct for multiple comparisons 
across space, which is generally more robust and avoids the need for the arbitrary 
initial cluster-forming threshold. Significance was set at a TFCE-corrected P < 
0.05. Differences between offspring and control subjects were assessed and 




diffusion parameters, the same model was used, although with contrasts of 





Characteristics of the study population are shown in Table 4.1. In total, 356 
subjects participated in the study, 185 offspring and 171 control subjects. The 
mean age of each group was 66 years, with a lower female percentage among 
offspring (44%) compared with control subjects (61%). More control subjects 
had a history of diabetes mellitus (9% vs 2%, P = 0.02). No differences were 
found concerning other comorbidities. 
 
Table 4.1 Characteristics of the study population 
 Offspring (n = 185) Controls (n = 171) P 
Demographics    
   Age (years) 66 (6) 66 (7) 0.77 
   Women 82 (44) 104 (61) 0.002* 
   Right-handedness 165 (90) 151 (89) 0.92 
Comorbidities    
   Myocardial infarction 3 (2) 5 (3) 0.39 
   Stroke 4 (2) 4 (3) 0.88 
   Hypertension 35 (21) 42 (28) 0.15 
   Diabetes mellitus 4 (2) 13 (9) 0.02* 
   Malignancies 13 (8) 17 (11) 0.27 
Values are numbers (percentage) for dichotomous variables or means (standard 
deviation) for continuous variables. * P < 0.05. 
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Brain tissue diffusion parameters and chronological age 
FA, AxD, RD, and MD of grey matter, white matter, and subcortical grey matter 
structures were quantified globally in the whole study population to assess their 
association with chronological age (Tables 4.2 and 4.3). FA of all structures 
decreased with increasing chronological age, except for cortical grey matter, 
amygdala, caudate nucleus, nucleus accumbens, and putamen. AxD rose with 
increasing chronological age in all structures, except for the pallidum. Likewise, 
RD and MD also rose with increasing chronological age in all structures, except 
for the nucleus accumbens. No sex differences in the association of chronological 
age with brain tissue diffusion parameters were found. 
Figure 4.1 shows the spatial distribution of age-related changes of white matter 
FA (see Fig. 4.1A) and white matter AxD, RD, and MD (see Fig. 4.1B) within 
the white matter skeleton. FA of the main white matter tracts was negatively 
associated with chronological age (P < 0.003) except for the callosal splenium 
and partly the corona radiata. RD was positively associated with chronological 
age (P < 0.003) in predominantly the same regions of the main white matter tracts, 
whereas the positive association of AxD and MD with chronological age (P < 
0.003) was more widespread, including the splenium of the corpus callosum and 
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Table 4.3 FA, AxD, RD, and MD of subcortical grey matter structures and their association with chronological age 




(n = 356) 
45-61; 58 
(n = 96) 
62-65; 64 
(n = 90) 
66-69; 68 
(n = 76) 
70-84; 74 
(n = 94) 
P 
Amygdala       
   FA 0.222 (0.001) 0.223 (0.002) 0.225 (0.002) 0.224 (0.002) 0.217 (0.002) 0.01 
   AxD (x 10-3) (mm2/s) 1.049 (0.004) 1.024 (0.007) 1.044 (0.008) 1.051 (0.008) 1.082 (0.009) <0.001* 
   RD (x 10-3) (mm2/s) 0.760 (0.003) 0.737 (0.005) 0.753 (0.007) 0.764 (0.007) 0.791 (0.008) <0.001* 
   MD (x 10-3) (mm2/s) 0.850 (0.003) 0.831 (0.005) 0.843 (0.006) 0.855 (0.006) 0.877 (0.008) <0.001* 
Caudate nucleus       
   FA 0.268 (0.002) 0.269 (0.003) 0.270 (0.003) 0.270 (0.003) 0.264 (0.003) 0.04 
   AxD (x 10-3) (mm2/s) 1.270 (0.012) 1.184 (0.019) 1.242 (0.021) 1.273 (0.026) 1.389 (0.026) <0.001* 
   RD (x 10-3) (mm2/s) 0.884 (0.011) 0.817 (0.017) 0.857 (0.018) 0.882 (0.022) 0.983 (0.024) <0.001* 
   MD (x 10-3) (mm2/s) 0.993 (0.010) 0.933 (0.016) 0.982 (0.019) 1.004(0.022) 1.069 (0.023) <0.001* 
Hippocampus       
   FA 0.216 (0.001) 0.219 (0.001) 0.218 (0.001) 0.217 (0.001) 0.210 (0.002) <0.001* 
   AxD (x 10-3) (mm2/s) 1.204 (0.004) 1.178 (0.006) 1.189 (0.007) 1.207 (0.007) 1.245 (0.007) <0.001* 
   RD (x 10-3) (mm2/s) 0.880 (0.003) 0.852 (0.005) 0.865 (0.005) 0.881 (0.006) 0.922  (0.006) <0.001* 
   MD (x 10-3) (mm2/s) 0.983 (0.003) 0.960 (0.005) 0.973 (0.006) 0.989 (0.006) 1.019 (0.006) <0.001* 
Nucleus accumbens       
   FA 0.242 (0.001) 0.237 (0.002) 0.243 (0.002) 0.243 (0.002) 0.244 (0.002) 0.02 
   AxD (x 10-3) (mm2/s) 0.924 (0.002) 0.915 (0.004) 0.922 (0.004) 0.922 (0.005) 0.936 (0.006) 0.001* 
   RD (x 10-3) (mm2/s) 0.655 (0.002) 0.654 (0.003) 0.652 (0.003) 0.654 (0.004) 0.661 (0.004) 0.10 
   MD (x 10-3) (mm2/s) 0.742 (0.002) 0.738 (0.003) 0.741 (0.003) 0.743 (0.004) 0.748 (0.004) 0.04 
Pallidum       
   FA 0.378 (0.001) 0.383 (0.003) 0.386 (0.003) 0.374 (0.003) 0.368 (0.003) <0.001* 
   AxD (x 10-3) (mm2/s) 1.020 (0.003) 1.013 (0.004) 1.020 (0.005) 1.017 (0.006) 1.031 (0.006) 0.003 
   RD (x 10-3) (mm2/s) 0.568 (0.002) 0.558 (0.003) 0.560 (0.003) 0.571 (0.004) 0.585 (0.004) <0.001* 
   MD (x 10-3) (mm2/s) 0.716 (0.002) 0.709 (0.003) 0.713 (0.003) 0.720 (0.004) 0.726 (0.003) <0.001* 
Putamen       
   FA 0.269 (0.001) 0.269 (0.001) 0.272 (0.002) 0.268 (0.002) 0.269 (0.002) 0.28 
   AxD (x 10-3) (mm2/s) 0.924 (0.002) 0.913 (0.003) 0.917 (0.003) 0.922 (0.005) 0.944 (0.005) <0.001* 
   RD (x 10-3) (mm2/s) 0.615 (0.002) 0.604 (0.002) 0.608 (0.003) 0.617 (0.004) 0.631 (0.004) <0.001* 
   MD (x 10-3) (mm2/s) 0.712 (0.001) 0.707 (0.002) 0.708 (0.002) 0.711 (0.003) 0.725 (0.003) <0.001* 
Thalamus       
   FA 0.336 (0.001) 0.339 (0.001) 0.337 (0.002) 0.335 (0.001) 0.332 (0.002) <0.001* 
   AxD (x 10-3) (mm2/s) 1.253 (0.008) 1.210 (0.012) 1.227 (0.015) 1.266 (0.016) 1.312 (0.017) <0.001* 
   RD (x 10-3) (mm2/s) 0.793 (0.006) 0.752 (0.008) 0.774 (0.012) 0.807 (0.012) 0.842 (0.014) <0.001* 
   MD (x 10-3) (mm2/s) 0.936 (0.006) 0.903 (0.009) 0.910 (0.011) 0.951 (0.012) 0.990 (0.015) <0.001* 
Probability values are adjusted for sex and for affiliation with the offspring or control group. Probability values are corrected 
for multiple comparisons using Bonferroni post hoc test. 
* Probability values that remain significant after Bonferroni correction. 





Figure 4.1 Age-related changes of white matter fractional anisotropy (FA), axial diffusivity (AxD), 
radial diffusivity (RD), and mean diffusivity (MD) in the whole study population. (A) Red colour 
indicates white matter regions showing age-related decrease of FA. (B) Regions of age-related 
increase in AxD (blue), RD (orange), and MD (pink; all P < 0.003). Results and mean white matter 
skeleton (green) are projected on the mean FA image of all study participants.  
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Brain tissue diffusion parameters and biological age 
To assess the association of biological age with brain tissue diffusion parameters, 
offspring were contrasted with control subjects. Mean whole brain white matter 
FA was higher in offspring (mean FA (SE) = 0.3232 (0.0009)) compared to 
control subjects (mean FA (SE) = 0.3212 (0.0009)) adjusted for age and sex (P = 
0.04). After additional correction for family relationships among the offspring, 
the P value for the difference in white matter FA between offspring and control 
subjects changed from 0.04 to 0.06. Exclusion of study participants with a history 
of stroke or myocardial infarction as well as additional adjustment for history of 
diabetes mellitus and hypertension did not alter the results. The differences in 
whole brain white matter FA between offspring and control subjects were similar 
at all ages and for both sexes. No differences in mean whole brain white matter 
AxD, RD, or MD between offspring and control subjects were found. 
When differences in white matter diffusion parameters between offspring and 
control subjects were assessed voxel-wise, regions of higher white matter FA as 
well as lower white matter RD were found in offspring as compared to control 
subjects. The spatial distribution of the observed differences in white matter FA 
and RD between both groups is shown in Figure 4.2. Offspring showed preserved 
white matter integrity in the callosal genu and body as expressed in higher FA 
(see Fig. 4.2A) and lower RD values (see Fig. 4.2B) in these regions (both P < 
0.003). Taking the annual rate of change for FA (-0.000578; adjusted for sex and 
affiliation with the offspring or control group) and the age- and sex-adjusted β of 
the difference between offspring and control subjects in FA (-0.00261) into 
account, offspring can be considered 4.5 years “biologically younger” compared 








Figure 4.2 Differences in white matter fractional anisotropy (FA) and radial diffusivity (RD) 
between offspring and control subjects. (A) Regions of higher white matter FA and (B) lower white 
matter RD in offspring as compared to control subjects are displayed in red and yellow (both P < 
0.003). Results and mean white matter skeleton (green) are projected on the mean FA image of the 
whole study population. 
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There were few differences in diffusion parameters of cortical and subcortical 
grey matter between offspring and control subjects, and none would have 
survived Bonferroni correction. The significant uncorrected differences are listed 
here for completeness: mean FA of the nucleus accumbens was higher (P = 0.04) 





The most important finding of this study is that offspring of nonagenarian siblings 
show preserved white matter integrity predominantly in the callosal genu and 
body as compared to environment- and age-matched control subjects, 
independent of cardiovascular comorbidities or risk factors. Moreover, this study 
demonstrates that grey matter, white matter, and subcortical grey matter 
structures show specific patterns of age-related changes of tissue integrity. 
Our findings suggest that preserved white matter integrity marks the phenotype 
of familial longevity and metabolic health in middle age. The genu and body of 
the corpus callosum were the most representative parts of the brain, showing more 
highly preserved white matter microstructural integrity in offspring of 
nonagenarian siblings as compared to control subjects. It is likely that these 
features are driven by the genetic component involved in familial longevity. A 
study on the heritability of the callosal microstructure in monozygotic and 
dizygotic elderly male twins has shown that both the callosal genu and splenium 
are under significant genetic control. Genetic relative to environmental influence 
on white matter FA was higher in the callosal splenium (67% genetic, 33% 
environmental) than in the genu (49% genetic, 51% environmental) 113. Chiang 
et al 120 have demonstrated high heritability of white matter integrity in bilateral 




dizygotic twins, which has been shown to be additionally influenced by 
socioeconomic status and intelligence quotient 114. AxD is assumed to reflect 
axonal size and extra-axonal space, whereas RD is sensitive to (age-related) 
differences in myelination. By contrast, FA, as a summary measure reflecting the 
extent to which AxD exceeds RD, seems less specific concerning underlying 
microstructural changes 103. In our study, the age-related decrease of white matter 
FA was accompanied by age-related increases in AxD as well as RD and MD in 
the whole study population, showing an anterior to posterior gradient, which was 
more pronounced for FA and RD as compared to AxD and MD. This is in line 
with results from previous studies 101, 103, 106, 107, 109. The observed anterior to 
posterior gradient lends support to a “last in first out theory,” 121 assuming that 
the predominantly frontally located late-myelinating regions, which consist of 
thinner myelinated axons, are more prone to age-related myelin breakdown 122. 
Against the backdrop of these findings, our results suggest that both offspring and 
control subjects show common age-related loss of white matter microstructural 
integrity, which is particularly less marked in the callosal genu and body of the 
offspring, structures that have been reported to be most affected by chronological 
aging and to be at the same time under significant genetic control. In terms of 
white matter integrity, offspring with the propensity to become long-lived can be 
considered 4.5 years “biologically younger” than environment- and age-matched 
control subjects. Moreover, recent studies have shown that age-related WML in 
otherwise healthy elderly subjects were accompanied by a decrease in callosal 
FA and an increase in callosal RD 123, 124. Offspring also showed lower 
periventricular as well as subcortical WML load compared to control subjects 115. 
Hence, preserved white matter integrity of the callosal genu and body among the 
offspring might be a reflection of a lower amount of spatially remote white matter 
damage. 
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One of the strengths of our study is its unique design of comparing middle-aged 
individuals who have a genetically determined higher propensity to become long-
lived compared to their spouses as environment- and age-matched controls. This 
will allow us to gain more insight into the relevance of age-related changes of the 
brain, which are frequently detected on MRI scans of elderly individuals. With 
the inclusion of the partners of the offspring as the control group, the two groups 
were highly comparable with regard to their socioeconomic and geographical 
background. Finally, our inclusion algorithm resulted in a large study sample, 
which allowed us to investigate even small differences between the two groups. 
Study subjects were relatively young for age-related changes of the brain, which 
is a limitation of this study. Because differences between the two groups were 
likely to be small, a higher mean age of the study groups would probably have 
facilitated the detection of differences. Moreover, not all offspring would have 
inherited the beneficial longevity-predisposing effects, which are consequently 
diluted with respect to the genetic longevity component. There are limitations 
inherent to the chosen DTI analysis approach. A whole brain analysis approach 
is particularly prone to distortions at tissue interfaces caused by different 
magnetic susceptibility of brain tissues, image stretch or compression caused by 
eddy currents, or partial volume between different brain tissues. Moreover, the 
use of TBSS to assess the spatial distribution of changes in FA, AxD, RD, and 
MD does not accommodate the potentially confounding effect of WML on the 
proper calculation of the white matter skeleton 125. Finally, it cannot be totally 
precluded that the presented differences between offspring and control subjects 
might be false-positive results due to chance alone; therefore, the findings should 
be considered as hypothesis generating rather than conclusive. 
In conclusion, this is the first study to compare brain tissue diffusion parameters 
between middle-aged and elderly offspring of nonagenarian siblings and control 




control subjects show common age-related loss of white matter microstructural 
integrity, which is less marked in the callosal genu and body among the offspring, 
independent of cardiovascular comorbidities or risk factors. In terms of white 
matter microstructure, offspring of nonagenarian siblings can be considered 4.5 
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Background and purpose: 
This study aimed to investigate whether magnetization transfer imaging (MTI) 
parameters of cortical grey and white matter and subcortical grey matter 
structures differ between subjects enriched for human familial longevity and 
control subjects to provide a thorough description of the brain phenotype of 
familial longevity. Moreover, we aimed to describe cerebral aging effects on MTI 
parameters in an elderly cohort. 
 
Methods: 
All subjects were included from the Leiden Longevity Study and underwent 3 
Tesla MTI of the brain. In total, 183 offspring of nonagenarian siblings, who are 
enriched for familial factors of longevity, were contrasted with 163 
environmentally and age-matched controls. 
 
Results: 
No differences in cortical and subcortical grey matter and white matter MTI 
parameters were found between offspring and control subjects using histogram-
based and voxel-wise analyses. Cortical grey matter and white matter MTI 
parameters decreased with increasing chronological age (all p < 0.001). Decrease 
of white matter magnetization transfer ratio (MTR) was homogeneous throughout 
the whole mean white matter skeleton except for parts of the callosal splenium 
and partly the posterior limb of the internal capsule and superior region of the 
corona radiata (p < 0.05). Mean MTR of subcortical grey matter structures 
decreased with increasing age (p amygdala, caudate nucleus and putamen < 
0.001; p pallidum = 0.001, p thalamus = 0.002). 
 




The brain phenotype of human familial longevity is - at a mean age of 66 years - 







The human brain undergoes notable structural changes during the normal aging 
process. The human lifespan is known to be influenced by genes as well as 
environmental factors 126 and it has been reported that extreme longevity is at 
least partly clustered in families 127. Studying the brain phenotype in familial 
longevity is a valuable tool to learn more about the relevance of common age-
related brain changes. 
 
The Leiden Longevity Study was designed to investigate which factors in middle-
aged humans associate with familial longevity. Offspring of long-lived 
nonagenarian siblings, who as a group are predisposed to become long-lived, are 
contrasted with their partners who represent the general population and serve as 
control subjects 6. Compared to the control subjects, aging in the offspring is 
marked by beneficial serum levels of lipid and thyroid parameters, preservation 
of insulin sensitivity, lower prevalence of myocardial infarction, hypertension, 
diabetes mellitus and use of cardiovascular medication and lower prevalence of 
cerebral white matter lesions (WML) and lacunar infarcts and preserved white 
matter microstructural integrity as measured using diffusion tensor imaging 
(DTI) 7-9, 86, 115, 128. Despite having the same chronological age, body mass index 
(BMI) and lifestyle 86 as the control subjects, the offspring generally display a 
younger biological age and for many other parameters appear healthier, such as 
for example better renal function 129 and a lower susceptibility to rheumatoid 
arthritis 130. 
Recently, magnetization transfer imaging (MTI) has been put forward as a highly 
sensitive tool to study changes in the myelin content of the brain. MTI contrast is 
based on magnetization transfer between protons, which are bound to 
macromolecules and therefore restricted in motion, and protons in water, which 
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can move freely 131. Within the brain, myelin water contributes disproportionately 
to the magnetization transfer ratio (MTR), which therefore has been suggested to 
be a relatively specific measure of myelin integrity 132-134. In recent studies it has 
been shown that MTR shows a steep decline in cortical and subcortical structures 
during lifespan (subjects aged 11 years-85 years) 135-143, indicating a decrease in 
myelin integrity. Still, in elderly subjects, 65 years of age and older, little MTI 
data are available 139-141. Thus, the aim of this paper is twofold: To describe and 
partly reproduce cerebral aging effects in MTI in an elderly cohort. Second to 
investigate whether the preserved white matter microstructural organization in 
human familial longevity is accompanied by preserved white matter tissue 
composition in the sense of preserved myelin integrity 144 to provide a thorough 





All subjects were included from the Leiden Longevity Study and underwent 3T 
MRI of the brain. The Leiden Longevity Study has been described more detailed 
elsewhere 6. In short, 421 Dutch Caucasian families were enrolled in the study 
between 2002 and 2006 based on the following inclusion criteria: (1) there were 
at least two living siblings per family, who fulfilled the age criteria and were 
willing to participate, (2) men had to be aged ≥ 89 years and women had to be 
aged ≥ 91 years and (3) the sib pairs had to have the same parents. Additionally, 
offspring of these long-lived siblings were included as they have a 35% lower 
mortality rate compared to the general population. Their partners, who share the 
same socio-economic and geographical background, were enrolled as age-




siblings, who are enriched for familial factors of longevity, were contrasted with 
163 environmentally and age-matched controls. 
The work described in this article has been carried out in accordance with the 
Code of Ethics of the World Medical Association (Declaration of Helsinki) and 
the study has been approved by the Medical Ethical Committee of the Leiden 
University Medical Centre (Leiden, The Netherlands). Written informed consent 
was obtained from all subjects. 
 
MRI acquisition 
All imaging was performed on a whole body MR system with a field strength of 
3T (Philips Medical Systems, Best, The Netherlands). The following images were 
acquired: 
3DT1-weighted: TR = 9.7 ms, TE = 4.6 ms, FA = 8°, FOV = 224 x 177 x 168 
mm, resulting in a nominal voxel size of 1.17 x 1.17 x 1.4 mm, covering the entire 
brain with no gap between slices. 
T2-weighted: TR = 4200 ms, TE = 80 ms, FA = 90°, FOV = 224 x 180 x 144 mm, 
matrix size 448 x 320, 40 transverse slices to cover the entire brain with a slice 
thickness of 3.6 mm with no gap between slices. 
FLAIR (fluid-attenuated inversion recovery): TR = 11000 ms, TE 125 ms, FA = 
90°, FOV = 220 x 176 x 137 mm, matrix size 320 x 240, 25 transverse slices to 
cover the entire brain with a slice thickness of 5 mm with no gap between slices. 
DTI (diffusion tensor imaging): TR = 9592 ms, TE = 56 ms, FA = 90°, FOV = 
220 x 220 x 128 mm, matrix size 112 x 110, 64 transverse slices to cover the 
entire brain with a slice thickness of 2 mm with no gap between slices, 32 
measurement directions, b-value = 1000. 
MTI (magnetization transfer imaging): TR = 100 ms, TE = 11 ms, FA = 9°, FOV 
= 224 x 180 x 144 mm, matrix size 224 x 169, 20 transverse slices to cover the 
entire brain with a slice thickness of 7.2 mm with no gap between slices. 




For analyses of MRI scans, different tools of the FSL (Functional MRI of the 
Brain Software Library) software package were used 64, 65. 
 
Image pre-processing 
Raw magnetization transfer scans were split in the M0-sequence (acquired 
without saturation pulse) and the M1-sequence (acquired after application of a 
saturation pulse). 
 
Quantification of cortical grey matter, white matter and subcortical grey matter 
MTI parameters using histogram analysis 
3D T1-weighted images were skull-stripped using BET (brain extraction tool) 68 
and segmented using FAST (FMRIB’s automated segmentation tool) 71 and 
FIRST (FMRIB’s integrated registration and segmentation tool) 75, resulting in 
individual brain masks for white matter, cortical grey matter, amygdala, caudate 
nucleus, hippocampus, pallidum, putamen and thalamus. Individual 3D T1-
weighted images were registered to the individual non-saturated M0 images using 
FMRIB’s linear image registration tool (FLIRT) 69, 70. Registration matrices from 
the previous step were used to coregister the non-saturated M0 images and the 
individual brain masks for all above mentioned brain structures so that the MTR 
maps could be masked with these brain masks. To correct for possible partial 
volume effects, an eroded mask of these segmentations was created by removing 
one voxel in-plane for all mentioned volumes-of interest (VOIs) 145. Individual 
MTR maps were calculated voxel by voxel following the equation MTR = (M0-
M1)/M0 and MTR histograms were generated for the above mentioned VOIs. 
Mean MTR, MTR peak height, normalized for the size of the VOI, and MTR 
peak location were calculated from each MTR histogram 146. Mean MTR reflects 




common MTR value. The peak height of the MTR histogram indicates the 
number of voxels showing the most common MTR value, and is a measure of 
uniformity of the underlying voxels in terms of MTR values. As the size of the 
VOI influences the number of voxels having the most common MTR value, MTR 
peak height was normalized by dividing the number of voxels with the most 
common MTR value by the number of voxels within the VOI. All MTI measures 
below -3 or above 3 standard deviations were excluded from statistical analysis. 
 
Automated segmentation of white matter lesions and quantification of MTR 
within these lesions 
For the automated measurement of white matter lesion (WML) volume, 3DT1-
weighted images were skull stripped 68 and the FLAIR and 3DT1 image were co-
registered 69, 70. The brain extracted FLAIR image was affine-registered to 
MNI152 standard space using FLIRT. A conservative MNI152 standard space 
white matter mask was used to extract the white matter from the FLAIR image. 
Subsequently, a threshold was set to identify which white matter voxels were 
hyperintense, followed by manually checking and editing for quality control. A 
mean MTR for all WML per subject was determined by masking the MTR maps 
with the registered WML masks. 
 
Voxel-based analysis of white matter MTR maps 
Voxel-wise statistical analysis of white matter MTR data was performed using 
TBSS (Tract-Based Spatial Statistics) 119, 147, which was based on the creation of 
a mean white matter skeleton from fractional anisotropy (FA) images, derived 
from a DTI sequence. FA images were created by fitting a tensor model to the 
raw diffusion data using FDT (FMRIB’s diffusion tool box) and then brain-
extracted using BET 68. All subjects’ FA images were aligned into MNI152 
standard space using non-linear registration (FNIRT) 73, 74. Next, the mean FA 
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image (from the whole study population) was created and thinned to generate a 
mean FA skeleton which represents the centres of all tracts common to the group. 
The threshold for the mean FA skeleton was set to 0.2. All subjects’ non-saturated 
M0 images and saturated M1 images were linearly registered to the DTI B0 
image, which is based on a raw T2 signal without diffusion weighting. MTR maps 
were calculated in “B0-space” in the same manner as described above. The 
resulting individual MTR maps were non-linearly registered into MNI152 
standard space using FNIRT 73, 74 and projected onto the mean FA skeleton. 
 
Statistical analysis 
If not otherwise stated, data are presented as mean with standard deviation (SD) 
or mean with standard error (SE). Differences in sex, handedness, and history of 
hypertension, diabetes mellitus, myocardial infarction, stroke and malignancies 
between offspring and control subjects were calculated using Chi-square tests. 
Differences in age were tested using independent samples t-tests. MTI measures 
of all brain tissues were normally distributed. A linear regression model was used 
to assess the association of brain tissue MTI parameters with chronological age, 
adjusted for sex and affiliation to the offspring or control group. Analyses of 
differences in MTI parameters between offspring and control subjects were 
adjusted for age and sex and robust standard errors were calculated to correct for 
family relationships among the offspring. For statistical analyses, Statistical 
Package for the Social Sciences (SPSS) software for windows (version 20.0) was 
used. Robust standard errors were calculated with STATA software for windows 
(version 12; STATA). 
For voxel-wise statistical analyses, the FSL randomize tool was used to perform 
permutation-based non-parametric testing (n = 5000 permutations) on the data. 
Threshold-Free Cluster Enhancement (TFCE) was applied to correct for spatial 




for the arbitrary initial cluster-forming threshold. To correct for multiple 
comparisons, permutation based Family Wise Error (FWE) correction was used 
as a thresholding method. Significance was set at a TFCE FWE-corrected p < 
0.05. Differences between offspring and control subjects were assessed, adjusted 
for age and sex. For the association between chronological age and MTI 
parameters, the same model was used though with contrasts of interest made for 




Characteristics of the study population are shown in Table 5.1. Imaging 
parameters were available for a total of 346 study participants, 183 offspring of 
long-lived siblings and 163 control subjects. The mean age of both groups was 
66 years with a lower female percentage of 44% among offspring compared to 
61% among control subjects (P = 0.002). More control subjects had a history of 
diabetes mellitus compared to offspring (7% versus 2%, P = 0.02). No differences 
were found concerning other morbidities. 
 
Brain tissue MTI parameters and biological age 
Cortical and subcortical grey matter and white matter MTI parameters were 
quantified globally using histogram analysis. No differences were found between 
offspring and control subjects (Table 5.2). Also within white matter lesions MTI 
parameters were similar in offspring and control subjects: Mean MTR (SE): 35.26 
(0.16) and 35.48 (0.17) respectively, P = 0.34; Mean normalized peak height 
(SE): 14.73 (5.39) and 14.82 (7.17) respectively, P = 0.85; Mean peak location: 
37.33 (2.73) and 37.77 (1.99) respectively, P = 0.28. Moreover, the association 
of chronological age with brain tissue MTI parameters was not different between 
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offspring and control subjects. Voxel-wise analysis of white matter MTR 
confirmed these results. 
 
Table 5.1 Characteristics of the study population 
 Offspring (n = 183) Controls (n = 163) P 
Demographics    
   Age (years) 66 (6.0) 66 (7.5) 0.82 
   Women 99 (61) 81 (44) 0.002* 
   Right-handedness 162 (89) 146 (90) 0.76 
Comorbidities    
   Hypertension 37 (20) 41 (25) 0.30 
   Diabetes mellitus 4 (2) 12 (7) 0.02* 
   Myocardial infarction 3 (2) 4 (2) 0.60 
   Stroke 4 (2) 3 (2) 0.85 
   Malignancies 13 (7) 16 (10) 0.30 
Values are numbers (percentage) for dichotomous variables or means (standard 





Table 5.2 MTI parameters of cortical and subcortical grey and white matter in offspring and control subjects 
 Mean (SE)  
 Offspring (n = 183) Controls (n = 163) P 
Grey matter    
   MTR (%) 33.51 (0.07) 33.50 (0.08) 0.61 
   norm. PH (%) 7.61 (0.09) 7.58 (0.08) 0.15 
   PL 36.23 (0.09) 36.40 (0.08) 0.14 
White matter    
   MTR (%) 39.41 (0.07) 39.43 (0.05) 0.97 
   norm. PH (%) 11.75 (0.17) 11.76 (0.17) 0.35 
   PL 40.62 (0.07) 40.73 (0.08) 0.23 
Amygdala    
   MTR (%) 36.72 (0.13) 36.98 (0.14) 0.92 
   norm. PH (%) 13.36 (0.21) 13.53 (0.22) 0.69 
   PL 38.15 (0.15) 38.48 (0.15) 0.22 
Caudate nucleus    
   MTR (%) 36.33 (0.14) 36.42 (0.17) 0.77 
   norm. PH (%) 8.96 (0.12) 8.91 (0.12) 0.32 
   PL 41.81 (0.14) 42.17 (0.20) 0.13 
Hippocampus    
   MTR (%) 38.36 (0.12) 38.45 (0.10) 0.73 
   norm. PH (%) 10.80 (0.16) 11.13 (0.17) 0.54 
   PL 40.72 (0.16) 40.96 (0.12) 0.20 
Pallidum    
   MTR (%) 38.37 (0.12) 38.36 (0.11) 0.61 
   norm. PH (%) 14.44 (0.23) 14.63 (0.23) 0.86 
   PL 38.72 (0.13) 38.75 (0.12) 0.46 
Putamen    
   MTR (%) 35.40 (0.12) 35.31 (0.12) 0.34 
   norm. PH (%) 12.82 (0.22) 12.99 (0.24) 0.81 
   PL 38.21 (0.11) 38.22 (0.11) 0.52 
Thalamus    
   MTR (%) 37.99 (0.14) 38.18 (0.18) 0.64 
   norm. PH (%) 10.93 (0.16) 11.06 (0.16) 0.87 
   PL 42.32 (0.13) 42.57 (0.18) 0.22 
Values represent means (standard error, SE). P-values (P) are adjusted for age and sex and corrected for family 
relationships among the offspring. MTR, magnetization transfer ratio; norm. PH, normalized peak height; PL, 
peak location.  
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Brain tissue MTI parameters and chronological age 
MTI parameters were calculated globally for cortical grey matter, white matter, 
and subcortical grey matter structures using histogram analysis and their 
association with chronological age was assessed cross-sectionally. All cortical 
grey and white matter MTI parameters decreased with increasing age (P < 0.001) 
(Table 5.3). Mean MTR of all measured subcortical grey matter structures 
decreased with increasing age (P amygdala, caudate nucleus, pallidum and 
putamen < 0.001; P hippocampus = 0.02, P thalamus = 0.002). Mean normalized 
peak height decreased with increasing age in the amygdala, pallidum and 
putamen (P < 0.001). Mean peak location decreased in the pallidum and putamen 
(P = 0.03 and P = 0.001 respectively). Results are shown in Table 5.4. No 
differences in the association of chronological age with brain tissue MTI 
parameters were found between males and females except for mean MTR of the 
putamen, which showed a faster age-related decrease in men compared to 
women. 
 
Table 5.3 Association of MTI parameters of cortical grey and white matter with chronological age 
 Standardized Beta P 
Grey matter   
   MTR (%) -0.37 < 0.001 
   norm. PH (%) -0.24 < 0.001 
   PL -0.20 < 0.001 
White matter   
   MTR (%) -0.33 < 0.001 
   norm. PH (%) -0.23 < 0.001 
   PL -0.25 < 0.001 
Values represent standardized Betas. P-values (p) are adjusted for sex and affiliation to the offspring 





Table 5.4 Association of MTI parameters of subcortical grey matter structures with 
chronological age 
 Standardized Beta P 
Amygdala   
   MTR (%) -0.23 < 0.001 
   norm. PH (%) -0.18 <0.001 
   PL -0.06 0.25 
Caudate nucleus   
   MTR (%) -0.23 < 0.001 
   norm. PH (%) -0.10 0.06 
   PL -0.002 0.97 
Hippocampus   
   MTR (%) -0.13 0.02 
   norm. PH (%) -0.09 0.10 
   PL -0.04 0.46 
Pallidum   
   MTR (%) -0.19 0.001 
   norm. PH (%) -0.21 <0.001 
   PL -0.12 0.03 
Putamen   
   MTR (%) -0.31 < 0.001 
   norm. PH (%) -0.28 < 0.001 
   PL -0.20 < 0.001 
Thalamus   
   MTR (%) -0.17 0.002 
   norm. PH (%) -0.06 0.27 
   PL -0.04 0.51 
Values represent standardized Betas. P-values (p) are adjusted for sex and affiliation to 
the offspring or control group. 
MTR, magnetization transfer ratio; norm. PH, normalized peak height; PL, peak location.  
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FSL-TBSS was performed to assess the spatial distribution of age-related changes 
of white matter MTR (Figure 5.1). White matter MTR decreased throughout the 
whole mean white matter skeleton except for partly the callosal splenium and 
posterior limb of the internal capsule and superior region of the corona radiata (P 
< 0.05). 
Figure 5.1 shows results from the voxel-
based assessment of age-related changes 
of white matter magnetization transfer 
ratio (MTR) in the whole study population 
using FSL-TBSS. Results are projected on 
the mean fractional anisotropy (FA) image 
of the whole study population which is 
derived from a diffusion tensor imaging 
(DTI) scan sequence. The mean white 
matter skeleton of the whole study 
population is shown in green colour. Red 
colour shows areas of statistically 
significant decrease of white matter MTR 








The finding that no differences in any of the MTI parameters were found in any 
of the cortical and subcortical grey and white matter regions between partner and 
offspring is at least remarkable. Our findings indicate that preserved white matter 
integrity in familial longevity cannot be attributed to a lower susceptibility to 
white matter demyelination during the aging process. Using DTI, we have shown 
recently that familial longevity is associated with preserved white matter integrity 
in the corpus callosum, as expressed in higher FA and lower radial diffusivity 
(RD) values in these regions 128. This corresponds to a biological age benefit of 
4.5 years 128. The interpretation of the data of the current study is impossible 
without incorporating these previous findings. 
 
During the past decade, brain aging has been studied extensively using DT and 
MT imaging techniques and several attempts have been made to correlate in vivo 
MRI findings with knowledge from histopathological studies. FA, which reflects 
the extent of directionality of diffusion of water protons, is predominantly found 
to decrease with aging and thought to be mainly influenced by axonal packing 
density as anisotropic diffusion also occurs in the absence of myelin 148. With FA 
being relatively unspecific concerning underlying microstructural changes (e.g. 
axonal loss, axonal damage or demyelination) 103, several studies have included 
other DTI measures, such as RD and (axial diffusivity) AxD, to characterize the 
underlying processes. Studies in mice have suggested that RD might be a specific 
measure of myelin status 134, 149. However, studies in humans have proven that 
increases in RD might not only be driven by loss of myelin but rather by a 
decrease in axon packing density through an increasing amount of extracellular 
water, which can be induced by different pathological processes 106. Likewise, 
MTR has been proposed to be a relatively specific measure of white matter 
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myelin status in humans 132, but has been shown to be additionally influenced by 
pathological conditions such as inflammation 150, 151, oedema 151, 152 and axon loss 
153. With both RD and MTR solely being not specific to white matter myelin loss, 
the combination of increased RD and reduced MTR can be considered highly 
suggestive of reduced myelin content. In humans, different region-specific 
patterns of age-related changes in white matter DTI parameters have been 
described 106, 107. In the corpus callosum which belongs to the predominantly 
frontally located late-myelinating regions consisting of thinner myelinated axons 
which are more prone to age-related myelin breakdown 122, an age-related 
decrease in FA was accompanied by increase in RD only or increase in RD as 
well as AxD 107, 121, 154. This raises the possibility that both patterns reflect 
different degrees of severity of the same underlying structural changes 106. MTR 
of the corpus callosum has been shown to decrease with increasing age 155. Our 
previous data indicated that FA was decreased and RD increased in the callosal 
genu in offspring of nonagenarian siblings compared to control subjects, whereas 
AxD and MTR of the callosal genu were not different between groups. These 
findings might suggest that familial longevity is not associated with a lower 
susceptibility to white matter demyelination in the callosal genu and that the 
described difference between groups is caused by different susceptibility to 
underlying pathology other than demyelination. Against the background of the 
findings of Bennett et al. 106 however, another possible explanation could be that 
underlying changes are still too subtle to be depicted by MTR at this mean age 
156. 
 
Our findings, in which we specifically study aging affects in an elderly cohort, 
add to the existing data in relatively younger subjects showing a steep decline in 
myelin integrity in cortical and subcortical structures during lifespan indicated by 




One of the strengths of our study is the large study sample of middle-aged to 
elderly subjects. Secondly, the study design of comparing elderly individuals with 
a familial propensity to become long-lived to their partners is unique and allows 
us to gain more insight into which of the multiple age-related changes of the brain, 
frequently detected on MRI-scans in the general aging population, are likely to 
be a relevant reflection of health. Thirdly, it should be noted that the partners of 
the offspring represent a control group matched for socio-economic and 
geographical background and lifestyle (as measured by FFQ). 
 
The fact that study subjects were relatively young concerning age-related changes 
of the brain belongs to the limitations of this study. As differences between 
offspring and control subjects are likely to be small, a higher mean age of the 
study groups would probably facilitate the detection of possible differences. 
 
In conclusion, this is the first study to compare macromolecular brain tissue 
integrity between elderly offspring of nonagenarian siblings and control subjects 
using MTI. Our findings suggest that, preserved white matter integrity of the 
callosal genu in familial longevity is not driven by a lower susceptibility to white 
matter demyelination during aging. Moreover, at a mean age of 66 years, both 
offspring and control subjects show similar age-related decline of 
macromolecular brain tissue integrity throughout the whole brain suggesting that 
the phenotype of familial longevity at that age is not characterized by preserved 
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Background and purpose: 
To investigate the association of coronary artery calcification (CAC) with 
cerebral small vessel disease in elderly individuals on the macrostructural and 
microstructural level, taking the spatial distribution of brain damage into account. 
 
Methods: 
We included 328 subjects who were participants from the Leiden Longevity 
Study. All participants underwent 3T MRI of the brain and CT of the coronary 
arteries. Ordinal/binary logistic and linear regression analysis was used to assess 
the association of CAC with various types of vascular brain damage. 
 
Results: 
Grey and white matter volumes were not associated with CAC. Increasing CAC 
was associated with a 1.3-fold higher probability to have more periventricular 
bands, periventricular white matter lesions (WML) in general and cerebral 
microbleeds (OR (95% CI) 1.34 (1.10-1.63), P = 0.004; OR (95% CI) 1.32 (1.08-
1.62), P = 0.006; OR (95% CI) 1.36 (1.01-1.81), P = 0.04 respectively). The 
probability to have lacunar infarcts was more than twofold (OR (95% CI) 2.15 
(1.10-4.20), P = 0.002). Neither subcortical WML nor total volume of WML was 
associated with CAC. Using diffusion tensor and magnetization transfer imaging, 
we found that CAC was associated with decreased microstructural grey matter 









Beyond focal ischemic brain lesions, CAC was associated with widespread 
microstructural brain pathology with a spatial distribution predominantly 







Arteriosclerosis is a common cause of morbidity and mortality in the elderly. In 
the entire cascade of atherosclerotic changes coronary artery calcification (CAC) 
occurs early in the formation of the atherosclerotic plaques. Therefore, CAC is 
widely accepted as marker of atherosclerosis 15. The widespread implementation 
of ultrafast computed tomography (CT) in clinical practice allows for the 
automated detection and quantification of CAC with high specificity and 
sensitivity 17. Prevalence of CAC increases with age and is higher in individuals 
with history of coronary artery disease compared to individuals without 17. 
 
Although CAC has been shown to be predictive of future cardiovascular events 
18, the clinical correlates of arteriosclerotic brain damage are still less obvious. 
Some studies have shown an association of increased CAC with brain atrophy 157-
159, where other studies indicated an association with macroscopic manifestations 
of cerebral small vessel disease, expressed in a higher prevalence of white matter 
lesions (WML), silent brain infarcts and cerebral microbleeds (CMB) 158-161. 
Recently, it has been shown that, in addition to these established macrostructural 
hallmarks of cerebral small vessel disease (brain atrophy, WML, lacunar infarcts, 
CMB 162), early signs of vascular brain damage may be picked up with diffusion 
tensor imaging (DTI) and magnetization transfer imaging (MTI) 163, even before 
macrostructural damage becomes overt 164. Beyond the potential higher 
sensitivity of DTI and MTI in detecting subtle changes, they allow for the 
visualization of the spatial distribution of potential cerebral changes. 
 
Since previous studies investigating the association between CAC and brain 
pathology have focused on macrostructural damage, the aim of the current study 
was to systematically assess the association of CAC with cerebral small vessel 
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disease in a large study cohort of elderly individuals on the macrostructural and 





Subjects were included from the Leiden Longevity Study, which has been 
described more detailed elsewhere 6. In short, 421 Dutch Caucasian families were 
enrolled between 2002 and 2006 based on the following inclusion criteria: (1) 
there were at least two living siblings per family, who fulfilled the age criteria 
and were willing to participate, (2) men had to be aged ≥ 89 years and women 
had to be aged ≥ 91 years and (3) the sib pairs had to have the same parents. 
Additionally, offspring of these long-lived siblings were included as they have a 
35% lower mortality rate compared to the general population. Their partners 
participated as environmentally and age-matched controls 6. For this study, 
subjects were recruited from the offspring and their spouses. Subjects were 
pooled for analyses. Study protocols meet the criteria of the Declaration of 
Helsinki. The study has been approved by the Medical Ethical Committee of the 
Leiden University Medical Centre (Leiden, The Netherlands). All subjects gave 
written informed consent. 
 
MRI acquisition 
All imaging was performed on a whole body MR system with a field strength of 
3T (Philips Medical Systems, Best, The Netherlands). 3D T1-weighted, T2-
weighted, FLAIR (fluid attenuated inversion recovery), DTI, MTI and T2*-







3DT1-weighted: TR = 9.7 ms, TE = 4.6 ms, FA = 8°, FOV = 224 x 177 x 168 
mm, nominal voxel size: 1.17 x 1.17 x 1.4 mm, no gap. 
T2-weighted: TR = 4200 ms, TE = 80 ms, FA = 90°, FOV = 224 x 180 x 144 mm, 
matrix size 448 x 320 x 40, no gap. 
FLAIR: TR = 11000 ms, TE 125 ms, FA = 90°, FOV = 220 x 176 x 137 mm, 
matrix size 320 x 240 x 25, no gap. 
DTI: TR = 9592 ms, TE = 56 ms, FA = 90°, FOV = 220 x 220 x 128 mm, matrix 
size 112 x 110 x 64, no gap, 32 measurement directions, b-value = 1000. 
MTI: TR = 100 ms, TE = 11 ms, FA = 9°, FOV = 224 x 180 x 144 mm, matrix 
size 224 x 169 x 20, no gap. 
T2*-weighted: TR = 45 ms, TE = 31 ms, FA = 13°, FOV = 250 x 175 x 112 mm. 
 
CT acquisition 
CAC was evaluated by measurement of the Agatston total coronary artery 
calcium score using a 320-multidetector row CT scanner (Aquilion ONE, 
Toshiba, Otawara, Japan). Scan range was planned between the carina and 
cardiac apex. An unenhanced volumetric CT was acquired with prospective 
ECG-triggering technique within a single heart beat during breath-hold at 
inspiration (0.35 s rotation time). Tube voltage was 120 kV and tube current 200-
400 mA, dependent on patient size and shape. Slice thickness was 0.5 mm. 
 
Assessment of CAC 
Non-overlapping 3.0 mm datasets were reconstructed and images were 
transferred to a workstation for analysis (Vitrea FX, version 1.0, Vital Images). 
Dedicated CT calcium score analysis software (VScore, Vital Images) was used. 
Pixels exceeding the threshold value of 130 HU were automatically recognized 
by the postprocessing tool and manually encircled in the courses of the coronary 
Coronary artery calcification associated brain pathology 
101 
 
arteries. The amount of CAC was automatically calculated according to Agatston 
et al. 17 and expressed as Agatston total score: 0 (Agatston score = 0), 1 (Agatston 
score = 1-10), 2 (Agatston score = 11-100), 3 (Agatston score = 101-400) and 4 
(Agatston score > 400). 
 
Parameters of brain structure and pathology 
Grey and white matter volumes 
Grey and white matter volumes were calculated using the FSL-tool SIENAX 
(Structural Image Evaluation, using Normalization, of Atrophy) 66, 67. SIENAX 
starts by extracting brain and skull images from the single whole-head input data 
68. The brain image is then affine-registered to MNI152 space 69, 70, using the skull 
image to determine the registration scaling. This is primarily done in order to 
obtain the volumetric scaling factor, to be used as a normalisation for head size. 
Next, tissue-type segmentation with partial volume estimation is performed 71 to 
calculate total volume of brain tissue, including separate estimates of volumes of 
grey and white matter. 
 
Assessment of WML, lacunar infarcts and CMB 
MRI scans were visualized using the freely available software MIPAV (Medical 
Image Processing, Analysis and Visualization). WML, lacunar infarcts and CMB 
were analysed blinded to subject identity, age, sex and descent. 
WML were defined as areas within the white matter with increased signal 
intensity on both FLAIR and T2-weighted images without mass-effect. WML 
were rated according to a slightly modified version of the semi-quantitative rating 
scale of Scheltens et al. 1. Periventricular and subcortical WML were rated 
separately and semi-quantitative regional scores were obtained by taking the size, 
amount and anatomical distribution of the lesions into account 115. For the 




stripped 67 and the FLAIR and 3DT1 image were co-registered in order to create 
a brain extracted FLAIR image 69, 70. This brain extracted FLAIR image was 
subsequently affine-registered to MNI152 standard space using the FMRIB’s 
Linear Image Registration Tool 69, 70. A conservative MNI152 standard space 
white matter mask was used to extract the white matter from the FLAIR image. 
Finally, a threshold was set to identify which white matter voxels were 
hyperintense, followed by manually checking and editing for quality control. The 
cerebellum and brainstem were excluded from this analysis. 
 
Presence and number of lacunar infarcts were assessed on FLAIR, T2-weighted 
and 3D T1-weighted images. They were defined as parenchymal defects within 
the white matter not extending into the cortical grey matter, with centrally a signal 
intensity corresponding to that of cerebrospinal fluid on all three imaging 
sequences, surrounded by a rim of increased signal intensity on FLAIR. Diameter 
of lacunar infarcts was defined to be > 2 mm. To distinguish lacunar infarcts from 
dilated perivascular spaces (Virchow-Robin-Spaces), lesions within the lower 
third of the corpus striatum and a diameter < 2 mm were excluded 87, 115. 
CMB were defined as focal areas of signal void on T2-weighted images, which 
increased in size on T2*-weighted images (“blooming effect”). In this way, CMB 
were distinguished from vascular flow voids. Symmetric hypointensities in the 
basal ganglia, likely to represent calcifications or nonhaemorrhagic iron deposits 
were disregarded 25. Number and localization (corticosubcortical junction, deep 
white matter and basal ganglia) were recorded 115. 
 
Assessment of grey and white matter microstructural integrity using DTI 128 
The individual raw diffusion tensor images were pre-processed to create 
individual FA, L1, L2, L3 and MD images using FDT (FMRIB’s Diffusion 
Toolbox) tools 116-118. The original images were corrected for effects of head 
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movement and eddy currents in the gradient coils, which induce stretches and 
shears in the DTI images, using affine registration to a non-diffusion-weighted 
reference volume. A diffusion tensor model was fitted to the eddy current 
corrected images to create individual FA, L1, L2, L3 and MD images. 
3D T1-weighted images were skull-stripped using BET (brain extraction tool) 68 
and subsequently segmented using FAST (FMRIB’s automated segmentation 
tool) 71 resulting in individual brain masks for grey matter and white matter. The 
segmented brain structures were aligned into common space using the linear 
registration tool FLIRT (FMRIB’s linear image registration tool) 69, 70. Mean 
fractional anisotropy (FA), axial diffusivity (AxD), radial diffusivity (RD) and 
mean diffusivity (MD) values were calculated for grey and white matter. All DTI 
measures below -3 or above 3 standard deviations were excluded from statistical 
analysis. 
Voxel-wise statistical analysis of white matter FA data was performed using 
TBSS (Tract-Based Spatial Statistics) 119. All subjects' FA data were aligned into 
common space using the nonlinear registration tool FNIRT (FMRIB’s nonlinear 
image registration tool) 73, 74. A mean FA image was created and thinned to create 
a mean FA skeleton representing the centres of all tracts common to the group. 
Each subject's aligned FA data was projected onto this skeleton. Likewise, 
individual AxD, RD and MD images were prepared for voxel-wise statistics. 
 
Assessment of grey and white matter microstructural integrity using MTI 
Raw magnetization transfer scans were split in the M0-sequence (acquired 
without saturation pulse) and the M1-sequence (acquired after application of a 
saturation pulse). 
First, cortical grey matter and white matter MTI parameters were quantified using 
histogram analysis. 3D T1-weighted images were skull-stripped using BET (brain 




tool) 71 resulting in individual brain masks for cortical grey matter and white 
matter. All individual 3D T1-weighted images were registered to the individual 
non-saturated M0 images using FMRIB’s linear image registration tool (FLIRT) 
69, 70. Registration matrices from the previous step were used to coregister the non-
saturated M0 images and the individual brain masks for the above mentioned 
brain structures so that the magnetization transfer ratio (MTR) maps could be 
masked with these brain masks. To correct for possible partial volume effects, an 
eroded mask of these segmentations was created by removing one voxel in-plane 
for all mentioned volumes-of interest (VOIs) 145. Individual MTR maps were 
calculated voxel by voxel following the equation MTR = (M0-M1)/M0 and MTR 
histograms were generated for grey matter and white matter. Mean MTR, MTR 
peak height, normalized for the size of the VOI, and MTR peak location were 
calculated from each MTR histogram 146. Mean MTR reflects the average MTR 
value per structure. MTR peak location reflects the most common MTR value. 
The peak height of the MTR histogram indicates the number of voxels showing 
the most common MTR value, and is a measure of uniformity of the underlying 
voxels in terms of MTR values. As the size of the VOI influences the number of 
voxels having the most common MTR value, MTR peak height was normalized 
by dividing the number of voxels with the most common MTR value by the 
number of voxels within the VOI. All MTI measures below -3 or above 3 standard 
deviations were excluded from statistical analysis. 
Subsequently, voxel-based analysis of cortical grey matter MTR maps was 
performed. MTR maps, which were coregistered to the individual 3D T1-
weighted images, were processed according to the optimized voxel-based 
morphometry protocol of Good et al. 54, 72, carried out with FSL tools 64. Tissue-
type segmentation was performed on the brain-extracted MTR images using 
FAST4 71. The resulting grey matter partial volume MTR maps were aligned to 
MNI (Montreal Neurological Institute) 152 standard space using the non-linear 
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registration tool FNIRT (FMRIB’s non-linear registration tool) 73, 74. To improve 
the quality of segmentation and normalization, a study-specific MTR template 
was created by averaging the obtained registered MTR maps of all study 
participants. The native individual MTR maps were non-linearly re-registered to 
this template. The segmented images were smoothed with an isotropic Gaussian 
kernel with a sigma of 3 mm. 
Next, voxel-wise statistical analysis of white matter MTR data was performed 
using TBSS (Tract-Based Spatial Statistics) 119. This analysis was based on the 
creation of a mean white matter skeleton from fractional anisotropy (FA) images 
as described above. All subjects’ non-saturated M0 images and saturated M1 
images were linearly registered to the DTI B0 image, which is based on a raw T2 
signal without diffusion weighting. MTR maps were calculated in “B0-space” in 
the same manner as described above. The resulting individual MTR maps were 
non-linearly registered into MNI152 standard space using FNIRT 73, 74 and 
projected onto the mean FA skeleton. 
 
Statistical analysis 
For statistical analyses, Statistical Package for the Social Sciences (SPSS) 
software for windows (version 20.0) was used. For all analyses, significance 
threshold was set at P < 0.05. 
 
Analysis of variance was used to assess changes in age across the five CAC score 
groups. Differences in sex and descent were tested using a Chi-square test. 
Analyses of differences in vascular risk profile (Table 6.1) were adjusted for age, 
sex and descent. Logistic regression and analysis of covariance was used were 
appropriate. 
For categorical outcome parameters, ordinal and binary logistic regression were 




regression analysis was performed to assess differences in continuous outcome 





Characteristics of the study population are presented in Table 6.1 for the total 
study cohort and five CAC score groups separately. In total, 328 subjects with a 
mean age of 66 years participated in the study. With increasing CAC, age, history 
of hypertension and diabetes increased, whereas the relative amount of women 
within the group decreased. There were no differences between CAC groups 
concerning other vascular risk factors (Table 6.1). 
 
CAC and macrostructural brain damage 
The associations of CAC with grey and white matter volumes are shown in Table 
6.2. No significant associations were found. 
Tables 6.2 and 6.3 show the association of CAC with periventricular and 
subcortical WML, volume of WML, presence of lacunar infarcts and CMB. 
Increasing CAC was associated with an approximately 1.3-fold higher probability 
to have more periventricular bands, periventricular WML in general and CMB 
(OR (95% CI) 1.34 (1.10-1.63), P = 0.004; OR (95% CI) 1.32 (1.08-1.62), P = 
0.006; OR (95% CI) 1.36 (1.01-1.81), P = 0.04 respectively). Moreover, 
increasing CAC was associated with a more than twofold probability to have 
lacunar infarcts (OR (95% CI) 2.15 (1.10-4.20), P = 0.002). Subcortical WML 
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Table 6.1 Characteristics of the study population 














Demographics        
   Age (years) 65.6 (6.9) 62.3 (6.9) 67.5 (6.2) 65.5 (6.2) 68.5 (5.2) 70.1 (6.1) < 0.001 
   Women 175 (53.4) 85 (74.6) 24 (55.8) 38 (46.3) 19 (36.5) 9 (24.3) < 0.001 
   Offspring 173 (52.7) 63 (55.3) 28 (65.1) 32 (39.0) 31 (59.6) 19 (15.4) 0.50 
Vascular risk profile       
   Hypertension 76 (26.0) 17 (17.0) 6 (15.4) 20 (26.7) 14 (31.1) 19 (57.6) < 0.001 
   MI 4 (1.3) 0 (0) 0 (0) 1 (1.3) 3 (6.5) 0 (0) 0.35 
   Diabetes 14 (4.7) 1 (1.0) 1 (2.6) 3 (3.9) 2 (4.4) 7 (20.0) 0.004 
   Stroke 9 (3.0) 3 (2.9) 0 (0) 1 (1.3) 3 (6.5) 2 (5.6) 0.59 
   Smoking 36 (11.1) 14 (12.5) 2 (4.8) 10 (12.2) 6 (11.5) 4 (10.8) 0.56 
   BMI 26.3 (3.7) 25.9 (3.4) 25.8 (2.9) 26.8 (3.6) 26.5 (4.6) 27.5 (3.6) 0.29 
   HDL-C 1.46 (0.43) 1.57 (0.45) 1.45 (0.46) 1.39 (0.37) 1.37 (0.44) 1.38 (0.41) 0.36 
   TG 1.74 (0.94) 1.57 (0.89) 1.71 (0.90) 2.00 (1.21) 1.77 (0.61) 1.65 (0.76) 0.32 
Values represent numbers (percentage) for dichotomous variables or means (standard deviation) 
for continuous variables. All analyses of differences in vascular risk profile were adjusted for age, 
sex and descent. 
BMI, body mass index (kg/m2); HDL-C, high density-lipoprotein-cholesterol (mmol/L); MI, 
myocardial infarction; TG, triglycerides (mmol/L). 
 
Table 6.2 Association of CAC with brain volumes and WML volume 
 Standardized Beta P 
Brain tissue volume (cm3)   
   Gray matter -0.045 0.37 
   White matter 0.006 0.91 
Total WML volume (mm3) 0.003 0.96 





Table 6.3 Association of CAC with WML, lacunar infarcts and CMB 
 OR 95% CI P 
White matter lesions    
   Periventricular    
     Frontal caps 1.20 0.995-1.46 0.06 
     Occipital caps 1.04 0.87-1.23 0.67 
     Bands 1.34 1.10-1.63 0.004 
     Total 1.32 1.08-1.62 0.01 
   Subcortical    
     Frontal 1.15 0.96-1.39 0.14 
     Temporal 0.96 0.80-1.15 0.65 
     Parietal 1.12 0.93-1.34 0.23 
     Occipital 0.995 0.83-1.19 0.96 
     Total 1.09 0.92-1.29 0.31 
Lacunar infarcts 2.15 1.10-4.20 0.002 
Cerebral microbleeds 1.36 1.01-1.81 0.04 
Values represent odds ratios (OR) (95% CI; 95% confidence interval). P-values 
are adjusted for age, sex and descent. 
 
CAC and microstructural brain damage 
Increasing CAC was associated with decreased microstructural grey matter 
integrity regarding all measured DTI and MTI parameters (all P < 0.05) except 
for grey matter AxD and mean MTR (P = 0.09 and P = 0.06 respectively) (Table 
6.4). Increasing CAC was associated with decreased microstructural white matter 
integrity, expressed in increasing MD and AxD and decreasing normalized MTR 
peak height (P = 0.05, P = 0.03 and P = 0.03 respectively). The association of 
CAC with white matter FA and RD was borderline significant (P = 0.09 and P = 
0.05 respectively) (Table 6.4). 
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Table 6.4 Association of CAC with mean grey and white matter DTI and MTI 
parameters 
 Standardized Beta P 
DTI (*1000)   
   FA   
     Grey matter -0.034 0.001 
     White matter -0.105 0.09 
   MD   
     Grey matter 0.105 0.04 
     White matter 0.098 0.05 
   AxD   
     Grey matter 0.086 0.09 
     White matter 0.109 0.03 
   RD   
     Grey matter 0.105 0.04 
     White matter 0.097 0.05 
MTI   
   Norm. MTR PH (/1000)   
     Grey matter -0.136 0.02 
     White matter -0.129 0.03 
   Mean MTR (*1000)   
     Grey matter -0.111 0.06 
     White matter -0.092 0.13 
   MTR PL (*1000)   
     Grey matter -0.145 0.02 
     White matter -0.018 0.77 
P-values are adjusted for age, sex and descent. 
FA, fractional anisotropy; MD, mean diffusivity; AxD, axial diffusivity; RD, radial 
diffusivity; Norm. MTR PH, normalized magnetization transfer ratio peak height; Mean 





Figures 6.1 and 6.2 depict the spatial distribution of changing white matter DTI 
and MTI parameters with increasing CAC. There was a widespread increase of 
MD, AxD and RD showing an anterior-posterior gradient most pronounced in the 
corpus callosum. CAC associated decrease of FA and MTR was restricted to 
small regions in the centrum semiovale and callosal genu (FA) and the posterior 
limb of the left internal capsule (MTR) respectively. Furthermore, figure 6.2 
shows the spatial distribution of decreasing grey matter MTR with increasing 
CAC. Changes were more or less symmetric and predominantly located in 
frontal/frontoparietal regions. 
 
Figure 6.1 Spatial distri-
bution of white matter 
DTI parameter changes 
with increasing CAC 
Dark blue (FA, fractional 
anisotropy), red (MD, 
mean diffusivity), light 
blue (AxD, axial diffu-
sivity) and orange (RD, 
radial diffusivity) indi-
cates white matter regions 
showing decrease (FA) or 
increase (MD, AxD and 
RD) of white matter DTI 
parameters with increa-
sing CAC (all P < 0.05). Results and mean white matter skeleton (green) are projected on the mean 
FA image of all study participants. Statistical analysis was adjusted for age, sex and descent.  




Figure 6.2 Spatial distribution of grey and white matter MTR changes with increasing CAC 
Orange (grey matter) and dark blue (white matter) colour indicates decrease of MTR with 
increasing CAC using FSL-VBM (grey matter) and FSL TBSS (white matter) (both P < 0.05). 
Results are projected on the MNI152 space T1-weighted image provided by FSL (grey matter) and 
the mean FA image of all study participants (white matter). Green colour shows mean white matter 







The most important finding of our study is that CAC is associated with cerebral 
small vessel disease reflected in higher prevalences of WML, lacunar infarcts and 
CMB and decreased microstructural grey and white matter integrity. CAC 
associated WML are predominantly located periventricular. White matter 
microstructural damage is widespread with an anterior-posterior gradient most 
pronounced in the corpus callosum. Loss of grey matter microstructural integrity 
is predominantly located in frontal/frontoparietal regions. 
 
Our findings suggest that CAC is not associated with grey and white matter 
atrophy. Vidal et al. described lower grey and white matter volumes with 
increasing CAC 159 whereas Bos et al. reported an association of CAC with lower 
grey but not white matter volumes 157. Another study described an association of 
CAC with higher ventricular grade which diminished after adjustment for age 158. 
Studies on the association between brain atrophy and markers of vascular disease 
have suggested that only subcortical atrophy (i.e. ventricular enlargement) but 
not cortical atrophy (i.e. sulcal widening) might have a microvascular aetiology 
165. Moreover, WML and lacunar infarcts were associated with brain atrophy 
independent of vascular risk factors, suggesting that neurodegenerative processes 
and vascular brain damage co-occur whereas the underlying pathophysiological 
mechanisms are not clear yet 166. Our study population was slightly younger 
compared to the Rotterdam Scan Study 157 and considerably younger compared 
to the AGES-Reykjavik Study 159. Possibly, brain volumetric changes in our study 
population were too subtle to be detected. Further studies are needed to unravel 
the possible vascular component of brain atrophy in elderly individuals. 
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CAC was associated with total periventricular WML load, more specifically 
periventricular bands and less pronounced frontal caps, but neither with 
subcortical WML nor total WML volume. Moreover, CAC was associated with 
presence of lacunar infarcts and CMB. By contrast, in the Rotterdam Scan Study, 
CAC was associated with total WML volume and presence of lacunar infarcts but 
not CMB 160. In the AGES-Reykjavik Study and another study on CAC and 
cerebral small vessel disease, presence of cerebral infarcts and CMB was 
associated with CAC, which is in line with our results. In both mentioned studies, 
total volume of WML and advanced WML respectively were associated with 
CAC 159, 161. Additionally, our results are in line with a study from Rosano et al., 
who reported higher white matter grade and more brain infarcts with increasing 
CAC in an elderly population 158. All the mentioned studies did not differentiate 
between periventricular and subcortical WML. It is commonly accepted that 
periventricular and subcortical WML differ regarding the underlying 
histopathology. The former are thought to represent disruption of the ependymal 
periventricular lining, subependymal gliosis, increased periventricular water 
content and myelin loss 167, 168. However, decline in total cerebral blood flow has 
been associated with increase in periventricular but not subcortical WML, 
suggesting a flow-component for the development of periventricular WML 169. 
Dependent on the lesion severity, subcortical WML have been associated with 
widening of periarteriolar spaces (punctuate lesions) 167, 170 and perivascular loss 
of myelin, fibre loss, gliosis and arteriosclerosis (early confluent and confluent 
lesions) 167 consistent with advanced microangiopathy 171. Furthermore, WML 
have been associated with inflammatory biomarkers of cerebrovascular disease 
172. Thus, the association of CAC with periventricular WML implies that CAC as 
overall marker of arteriosclerosis indicates low flow cerebrovascular damage. 
CAC is no marker of microangiopathic brain damage in the sense of subcortical 




reported an association between CAC and WML volumes. Possibly, in our study, 
subcortical WML were too subtle at this mean age of the study population. 
 
CAC is a marker of decreased white matter microstructural integrity, most 
pronounced with respect to an increase in AxD. This is conform the Rotterdam 
Scan Study 157. Increasing CAC was accompanied by an increase in MD, AxD 
and RD, showing an anterior-to-posterior gradient, which is a frequently 
described pattern of age-related changes of white matter integrity 106, 128. Vascular 
risk factors have been shown to be associated with loss of white matter integrity 
beyond the effects of age 173. Our findings suggest that CAC is a marker of white 
matter microstructural damage in a spatial distribution paralleling the detrimental 
effects of the aging process. The CAC associated decrease of FA was restricted 
to a small area in the centrum semiovale and callosal genu. As a summary 
measure FA reflects to what extent AxD exceeds RD and thus the orientational 
coherence of the underlying tissue and is therefore less specific concerning 
underlying microstructural changes 103, 104. Thus, increases in AxD and RD with 
increasing CAC do not necessarily have to be accompanied by a decrease in FA. 
CAC was associated with normalized white matter MTR peak height - a measure 
of uniformity of underlying voxels in terms of MTR values. Mean MTR was 
lower in all types of WML 174 and normal appearing brain tissue in individuals 
with known cerebrovascular risk factors 141. CAC can be considered as marker of 
vascular white matter damage on the macromolecular level. Decrease of white 
matter MTR with increasing CAC was restricted to the posterior limb of the left 
internal capsule. MTR has been proposed to be relatively specific for white matter 
myelin status 132, but is additionally influenced by pathological conditions such 
as inflammation 150, oedema 151 and axon loss 153. Likewise, RD has been 
suggested to be specific for myelin status in mice 134. Studies in humans have 
shown that increases in RD might rather be driven by decreased axon packing 
Coronary artery calcification associated brain pathology 
115 
 
density through an increase in extracellular water, which can be induced by 
different underlying pathological processes 106. Thus, it is not likely that the 
increase of RD with increasing CAC is driven by white matter demyelination. 
CAC associated grey matter damage was mainly located in frontal and less 
pronounced frontoparietal regions. This is in line with the fact that e.g. age-related 
loss of grey matter volume is more pronounced in frontal compared to occipital 
brain regions 31. Our findings suggest that CAC is a marker of early (vascular) 
grey matter damage again paralleling the detrimental effects of the aging process. 
One strength of our study is the large cohort of elderly individuals who underwent 
both coronary artery CT and brain MRI. Subjects were relatively young regarding 
the detection of subtle age-related vascular brain damage which belongs to the 
limitations. 
 
In conclusion, this is the first study to investigate CAC associated brain pathology 
in a large study population of elderly individuals on the macro- and 
microstructural level including the spatial distribution of brain pathology. Beyond 
focal ischemic brain lesions, CAC was associated with widespread 
microstructural brain pathology spatially predominantly paralleling the 
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Background and purpose: 
To investigate the prognostic value of cerebral microbleeds (CMB) regarding 
overall, cardiovascular-related, and stroke-related mortality and to investigate 
possible differences based on a cerebral amyloid angiopathy-type and nonlobar 
distribution of microbleeds. 
 
Methods: 
We included 435 subjects who were participants from the nested MRI substudy 
of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). Cox 
proportional hazard models were applied to estimate the risk of overall, 
cardiovascular-related, and stroke-related death associated with microbleeds in 
general and microbleeds with a lobar distribution suggestive of the presence of 




Subjects with > 1 CMB had a 6-fold risk of stroke-related death compared to 
subjects without CMB (hazard ratio, 5.97; 95% CI, 1.60–22.26; P = 0.01). The 
diagnosis of nonlobar microbleeds was associated with > 2-fold risk of 
cardiovascular death compared to subjects without microbleeds (hazard ratio, 
2.67; 95% CI, 1.23–5.81; P = 0.01). Subjects with probable cerebral amyloid 
angiopathy-type microbleeds had > 7-fold risk of stroke-related death compared 








This is the first study investigating the association between microbleeds and risk 
of overall, cardiovascular- related, and stroke-related mortality in an elderly 
population. Our findings indicate that the diagnosis of microbleeds is potentially 
of clinical relevance. Larger studies are needed to expand our observations and 






Cerebral microbleeds (CMB) are focal hemosiderin deposits that result from 
minimal blood leakage from damaged small vessels1 and can be regarded as 
markers of pathological vascular changes 25. Concerning histopathology, the two 
most common types of underlying small vessel damage are hypertensive 
vasculopathy and cerebral amyloid angiopathy (CAA) 23, 26, 27. The location and 
distribution of CMB depend on the type of underlying vasculopathy; whereas 
hypertensive CMB preferentially occur in deep brain regions such as the basal 
ganglia, thalamus, or brain stem, CAA-type CMB are mainly located in the 
cerebral lobes but never in deep brain regions 24, 25, 28, 29. CMB are commonly seen 
in patients with ischemic stroke 81, intracerebral haemorrhage 23, Alzheimer’s 
disease 175, traumatic brain injury-associated diffuse axonal injury 176, and also in 
healthy elderly individuals 21. The prevalence of CMB in the general population 
increases from ≈20% in subjects aged 60 to 69 years to ≈40% in subjects aged 80 
years and older 28. Presence of CMB was the strongest predictor of overall 
mortality among a range of MRI markers of vascular damage in a memory clinic 
population 22. It remains to be elucidated whether CMB are predictive of mortality 
in the general population. Furthermore, it is not known to what extent CMB are 
specifically associated with cardiovascular mortality or noncardiovascular 
disease. 
In the present study, we investigated the prognostic value of CMB regarding 
overall, cardiovascular-related, and stroke-related mortality in a population 
enriched for or at high risk for cardiovascular disease. Moreover, we investigated 
possible differences in prognostic value based on a CAA-type and nonlobar 
distribution of CMB. 
 
 






All subjects are participants from the nested MRI substudy of the PROspective 
Study of Pravastatin in the Elderly at Risk (PROSPER) 30. Inclusion criteria for 
the PROSPER were men or women aged 70 to 82 years with a total cholesterol 
of 4.0 to 9.0 mmol/L and a history of either ischemic or haemorrhagic stroke, 
transient ischemic attack, myocardial infarction, arterial surgery, or amputation 
for vascular disease, or one of the following risk factors for vascular disease: 
current smoker, hypertension diagnosed, diabetes mellitus, or fasting blood 
glucose > 7 mmol/L. Of the included subjects, 43% had symptomatic vascular 
disease. These subjects experienced symptoms > 6 months before entering the 
study. Exclusion criteria have been described in detail elsewhere 177. There were 
no specific inclusion criteria for the MRI substudy. All consenting subjects (646 
of the 1100 eligible Dutch participants) were enrolled in the Netherlands from 
May 2, 1998. CMB were scored on MRI scans obtained at the end of the study. 
Ninety-two subjects did not undergo an MRI scan because of the following 
reasons: 44 subjects were ill or had contraindications for MRI, 40 subjects had 
died, six subjects had withdrawn informed consent, and two could not undergo a 
scan because of technical problems 178. T2*-weighted scans for the detection of 
CMB were available for 435 subjects. Baseline characteristics of these 435 
subjects and the remaining 665 Dutch PROSPER participants were similar, 
except for the proportion of smokers, which was significantly higher among the 
665 Dutch participants (26.8% vs 20.5%; P = 0.02). Mortality of study 
participants was continuously followed-up after the official end of the study until 
December 31, 2009. The individual causes of death were obtained through the 
Central Bureau of Statistics of the Netherlands. All end points were adjudicated 




the criteria of the Declaration of Helsinki and were approved by the Medical 
Ethics Committees of each participating institution. Written informed consent 
was obtained from all participating patients. 
 
MRI acquisition 
All imaging was performed on an MR system operating at field strength of 1.5 T 
(Philips Medical Systems). Dual fast-spin echo (repetition time = 3000 ms; echo 
times = 27/120 ms; flip angle = 90°; slice thickness = 3 mm; 48 slices; no 
interslice gap; field of view = 220 x 220 mm; matrix = 256 x 204), fluid-
attenuated inversion recovery (FLAIR) (repetition time = 8000 ms; echo time = 
100 ms; inversion delay = 2000 ms; flip angle = 90°; slice thickness = 3 mm; 48 
slices; no interslice gap; field of view = 220 x 176 mm; matrix = 256 x 153), and 
T2*-weighted images (multislice gradient echo sequence; repetition time = 2593 
ms; echo time = 48 ms; flip angle = 60°; slice thickness = 6 mm; 22 slices; 
interslice gap = 6 mm; whole brain coverage; field of view = 220 x 198 mm; 




All MRI scans were read in consensus by two experienced raters (A.C.G.M.v.E. 
and M.A.v.B.), who were blinded to the clinical history. CMB were defined as 
focal areas of signal loss on T2-weighted images that increased in size on the 
T2*-weighted gradient-echo planar images (“blooming effect”) 25. In this way, 
CMB were differentiated from areas of signal loss based on vascular flow void. 
Areas of symmetrical hypointensity in the basal ganglia likely to represent 
calcification or nonhaemorrhagic iron deposits were disregarded. For each 
subject, number and location (corticosubcortical junction, deep white matter, 
basal ganglia, and infratentorial) of CMB were recorded. All study participants 
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were assigned to one of the following groups according to the number of CMB: 
no microbleeds, 1 microbleed, > 1 microbleed. 
Subsequently, we applied the Boston criteria for CAA to all subjects. The Boston 
criteria are designed to estimate the likelihood of the presence of CAA during life 
by means of location and number of intracerebral haemorrhages. We categorized 
subjects as having no microbleeds, possible CAA (MRI demonstrating a single 
lobar, cortical, or corticosubcortical haemorrhage without any other cause of 
haemorrhage), probable CAA (MRI demonstrating multiple lobar, cortical, or 
corticosubcortical haemorrhages without any other cause of haemorrhage), or 
microbleeds not qualifying for CAA (nonlobar microbleeds) 24, 179, 180. 
 
White matter lesions, atrophy, and cerebral infarction 
Segmentation of white matter lesions (WML), intracranial volume, and brain 
parenchyma volume was performed automatically using Software for Neuro-
Image Processing in Experimental Research 181, a program developed in-house 
for image processing. This segmentation was performed on the T2-weighted and 
FLAIR images. WML connected to the lateral ventricles were labelled as 
periventricular WML, and WML not connected to the lateral ventricles were 
labelled as deep WML 178. The volumes of periventricular WML and deep WML 
were calculated automatically by Software for Neuro-Image Processing in 
Experimental Research. All measurements were performed blinded to subject 
identity, age, and sex. A measure reflecting whole brain atrophy and hippocampal 
atrophy was calculated using the following equations: atrophy (%) = 
[(intracranial volume-parenchymal volume)/intracranial volume] x 100% and 
hippocampal atrophy (%) = (hippocampal volume/intracranial volume) x 100%, 
respectively 182, 183. Cortical infarcts were defined as cortical defects surrounded 
by a hyperintense zone on T2-weighted scans. Lacunar infarcts were defined as 




zone (≥ 3 mm, < 15 mm in diameter) on a T2-weighted scan. Dilated perivascular 
spaces were distinguished from infarcts on the basis of their location, form, and 
the absence of a hyperintense zone around the parenchymal defect. 
 
Statistical analysis 
For statistical analysis, SPSS software for windows (version 17.0.1; SPSS) was 
used. Kaplan-Meier survival curves for overall, cardiovascular-related, and 
stroke-related mortality were calculated for no, 1, and > 1 microbleed, possible 
and probable CAA-type CMB, and nonlobar microbleeds. We applied Cox 
proportional hazard models to estimate the risk of overall, cardiovascular-related, 
and stroke-related death associated with these microbleed categories in two 
different ways: adjusting for age, sex, and use of statins (Model 1; n = 435 for 
overall mortality, n = 434 for cardiovascular-related and stroke-related mortality; 
the cause of death of one subject was missing) and additionally adjusting for 
cardiovascular risk factors (alcohol use, smoking, body mass index, high-density 
lipoprotein cholesterol, systolic and diastolic blood pressure, and history of 
hypertension/diabetes mellitus/ischemic or haemorrhagic stroke/transient 
ischemic attack; Model 2; n = 418 for overall mortality, n = 417 for 
cardiovascular-related and stroke-related mortality; the cause of death of one 




Baseline characteristics of the study population are shown in Table 7.1. In total, 
435 participants with a mean age of 75.0 years and a female fraction of 43.6% 
were included in the present study. The mean follow-up duration for determining 
mortality was 7.0 (± 2.1) years. In this period, 153 subjects (34.9%) died, of 
whom 57 (37.3%) died of cardiovascular causes: 14 had an ischemic or 
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haemorrhagic stroke, 43 subjects died of cardiovascular causes not affecting the 
brain, and the cause of death of one subject was missing. The individual amount 
of CMB was not significantly different between subjects treated with statins and 
subjects treated with placebo (data not shown). History of hypertension was 
significantly associated with the diagnosis of CMB independent of the other 
mentioned cardiovascular risk factors (P = 0.005; data not shown). 
 
First, we investigated the risk of overall, cardiovascular-related, and stroke-
related death associated with the diagnosis of no, 1, or > 1 microbleed. Subjects 
with > 1 microbleed diagnosed had an increased risk of overall death compared 
to subjects without CMB after adjustment for age, sex, use of statins, and 
cardiovascular risk factors not reaching statistical significance (hazard ratio (HR), 
1.41; 95% CI, 0.87–2.27; P = 0.16). The risk of cardiovascular death for these 
subjects was broadly similar (HR, 1.78; 95% CI, 0.86–3.70; P = 0.12; Table 7.2). 
Strikingly, subjects with > 1 microbleed diagnosed had ≈6-fold risk of stroke-
related death compared to subjects without microbleeds after adjustment for age, 
sex, use of statins, and cardiovascular risk factors (HR, 5.97; 95% CI, 1.60–22.26; 





Table 7.1 Baseline characteristics of the study population 
Demographics  
   Total number of participants 435 
   Age (years) 75.0 (3.3) 
   Women 190 (43.7) 
   Use of statins 210 (48.3) 
Cardiovascular risk factors  
   Alcohol use (U/week) 6.66 (8.0) 
   Smoking 89 (20.5) 
   HDL-cholesterol (mmol/L) 1.31 (0.37) 
   BMI (kg/m2) 26.6 (3.6) 
   Systolic BP (mmHg) 156 (21) 
   Diastolic BP (mmHg) 84 (11) 
   History of hypertension 279 (64.1) 
   History of diabetes mellitus 66 (15.2) 
   History of stroke (ischemic or haemorrhagic) 
   or transient ischemic attack 
70 (16.1) 
MRI characteristics  
   Participants with microbleeds 104 (23.9) 
   Participants with CAA type microbleeds 72 (16.6) 
   Participants with non-lobar microbleeds 32 (7.4) 
   Brain atrophy (% of ICV) 27.2 (3.5) 
   Hippocampal volume (% of ICV) 0.5 (0.1) 
   Volume of WML (% of ICV) 0.5 (0.8) 
   Participants with lacunar infarcts 88 (20.2) 
   Participants with cortical infarcts 45 (10.3) 
Values represent numbers (percentage) for dichotomous variables or means (standard 
deviation) for continuous variables unless otherwise stated. 
CAA, cerebral amyloid angiopathy; BMI, body mass index; BP, blood pressure; HDL 
cholesterol, high-density lipoprotein cholesterol; ICV, intracranial volume; WML, white 
matter lesion. 
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Table 7.2 Risk of overall, cardiovascular-related mortality and stroke-related 
mortality associated with cerebral microbleeds 
  Model 1   Model 2  
Microbleeds d/n HR (95% CI) P d/n HR (95% CI) P 
Overall mortality n = 435   n = 418  
0 115/331 1.00 (reference)  109/320 1.00 (reference)  
1 15/52 0.76 (0.45-1.31) 0.33 12/47 0.70 (0.38-1.28) 0.24 
> 1 22/52 1.23 (0.78-1.95) 0.38 22/51 1.41 (0.87-2.27) 0.16 
Cardiovascular 
mortality 
n = 434   n = 417  
0 40/330 1.00 (reference)  39/319 1.00 (reference)  
1 7/52 1.05 (0.47-2.34) 0.91 4/47 0.60 (0.21-1.71) 0.34 
> 1 10/52 1.61 (0.80-3.24) 0.18 10/51 1.78 (0.86-3.70) 0.12 
Stroke-related 
mortality 
n = 434   n = 417  
0 9/330 1.00 (reference)  8/319 1.00 (reference)  
1 0/52 no cases  0/47 no cases  







d indicates deceased; HR, hazard ratio; n, total number of subjects. 
Values are HR adjusted for age, sex, and use of statins (Model 1) and additionally 
for cardiovascular risk factors (Model 2), respectively, with 95% CI. 
 
Figure 7.1 shows the corresponding Kaplan-Meier survival curves for overall 






Figure 7.1 Kaplan-Meier survival curves for cerebral microbleeds in general: (A) overall mortality, 
(B) cardiovascular mortality, and (C) stroke-related mortality. Lines represent cumulative survival 
for three microbleed categories: no microbleeds, 1 microbleed, and > 1 microbleed. 
 
Subjects with nonlobar microbleeds diagnosed had > 2-fold risk of cardiovascular 
death compared to subjects without CMB after adjustment for age, sex, use of 
statins, and cardiovascular risk factors (HR, 2.67; 95% CI, 1.23–5.81; P = 0.01; 
Table 7.3). This association remained unchanged after additional adjustment for 
other cerebral changes on MRI (cerebral and hippocampal atrophy, WML, 
cortical and lacunar infarctions; HR, 3.03; 95% CI, 1.34–6.85; P = 0.01).  




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The corresponding Kaplan-Meier survival curves are shown in Figure 7.2A. 
Approximately 65% of these subjects had CMB located in the basal ganglia 
diagnosed, 52% had cerebellar CMB diagnosed, 32% had lobar CMB diagnosed, 
13% had CMB located in the brain stem diagnosed, and 45% had CMB in at least 
two of the mentioned locations diagnosed. The HR for cardiovascular mortality 
were, respectively, 3.06, (95% CI, 1.12–8.34; P = 0.03; deceased/total number of 
subjects = 6/19, basal ganglia), 4.18 (95% CI, 1.57–11.11; P = 0.004; 
deceased/total number of subjects = 6/15, cerebellum), 2.51 (95% CI, 0.68–9.23; 
P = 0.17; deceased/total number of subjects = 3/10, lobar), and 1.62 (95% CI, 
0.19–14.12; P = 0.66; deceased/total number of subjects = 1/4 brain stem). 
Subjects with probable CAA-type microbleeds diagnosed were exposed to > 7-
fold risk of stroke-related death compared to subjects without CMB after 
adjustment for age, sex, use of statins, and cardiovascular risk factors (HR, 7.20; 
95% CI, 1.44–36.10; P = 0.02). The corresponding Kaplan-Meier survival curves 
are shown in Figure 7.2B. Neither probable CAA-type CMB nor possible CAA-
type CMB were associated with an increased risk of overall or cardiovascular 
death. Combining probable and possible CAA patients in one group did not 
change these results.  




Figure 7.2 Kaplan-Meier survival curves for cerebral microbleeds scored using the Boston criteria: 
(A) cardiovascular mortality and (B) stroke-related mortality. Lines represent cumulative survival 




The most important findings of this population-based study in elderly individuals 
are that nonlobar microbleeds are significantly and independently associated with 
cardiovascular mortality and that probable CAA-type microbleeds are 
significantly associated with stroke-related mortality. 
 
Nonlobar CMB seem to represent a sensitive marker of increased cardiovascular 
risk beyond traditional cardiovascular risk factors. Presence of nonlobar CMB 
was significantly associated with an increased risk of cardiovascular-related but 
not stroke-related death, independent of cardiovascular risk factors and other 
cerebral changes on MRI, such as cortical and hippocampal atrophy, WML, and 
cortical and lacunar infarctions, which have been partly shown to be associated 





CMB have been shown to be associated with primary and recurrent intracerebral 
haemorrhage 184-191, and especially nonlobar microbleeds are strongly associated 
with hypertension and elevated systolic blood pressure, the traditional risk factors 
for haemorrhagic and ischemic stroke 28, 192, 193. Against this background our 
results are striking, indicating that nonlobar CMB can be regarded as an 
additional marker of an unfavourable cardiovascular risk profile beyond 
traditional cardiovascular risk factors, such as hypertension or smoking, and other 
imaging markers of hypertension, such as left ventricular hypertrophy, which has 
been established as a predictor of excess cardiovascular mortality 194. Further 
studies will be needed to compare the predictive strength of nonlobar CMB 
against already-established imaging markers of cardiovascular mortality such as 
left ventricular hypertrophy. However, the value of this finding is limited by the 
small proportion of subjects with nonlobar CMB diagnosed who died from 
cardiovascular disease or stroke during follow-up. 
CAA-type CMB seem to be markers of an increased risk of stroke-related death, 
independent of cardiovascular risk factors. However, the number of subjects who 
died from stroke was small. Furthermore, we could not differentiate between 
haemorrhagic and ischemic stroke as primary outcome and therefore are not able 
to further comment about possible associations between CAA-type microbleeds 
and haemorrhagic or ischemic stroke. Further studies are needed to assess the 
validity and possible underlying mechanisms of the association between probable 
CAA-type microbleeds and stroke-related mortality. 
The association of CMB with mortality depends on the number of CMB 
diagnosed in subjects. We could show that subjects with 1 microbleed in general 
or possible CAA-type microbleeds diagnosed had no increased risk of mortality, 
whereas subjects with > 1 microbleed in general or probable CAA-type 
microbleeds diagnosed were exposed to an increased risk of death. Within the 
group of subjects with nonlobar microbleeds, presence of ≥ 1 CMB was 
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associated with an increased risk of mortality. Until now, there was only one 
study investigating the association between CMB and overall mortality in a 
memory clinic population 22. In this study, the diagnosis of ≥ 3 microbleeds was 
associated with an increased risk of overall death. However, because the 
conspicuity and therefore the accuracy of detection of CMB are strongly affected 
by the used MRI technique, available MRI field strength, and image post-
processing 25, it remains difficult to compare these studies. 
 
A strength of our study is the population-based setting in elderly individuals with 
or at high risk for vascular disease developing. Although our results might not be 
generalizable to the general elderly population, we were able to assess the 
predictive value of CMB in a population in which CMB are most likely to be 
clinically relevant. Furthermore, the large sample size and high prevalence of 
CMB in this specific population allowed us to assess the association between 
CMB and different outcome parameters, such as overall, cardiovascular-related, 
and stroke-related death, and to analyse these associations for different 
classifications of CMB and CMB in separate anatomic regions. However, there 
are also several limitations of this study. First, the adjudication of the primary 
outcome from the national registry instead of formal follow-up limited the 
possibility to reliably assess the association between CMB and different outcome 
parameters. One example is the missing differentiation between haemorrhagic 
and ischemic strokes. Second, the number of events during follow-up was 
relatively small, so the association between 1 microbleed in general or possible 
CAA and stroke-related mortality could not be assessed. Because we did not 
include other established neuroimaging markers of, for instance, cardiovascular 
mortality, such as left ventricular hypertrophy, in our study design we were not 
able to compare the predictive strength of CMB against these markers. Further 




to a small group of elderly individuals enriched for or at high risk for 
cardiovascular disease and therefore were neither generalizable to the whole 
study cohort nor to the general elderly population. 
 
In conclusion, this is the first study to our knowledge investigating the association 
between CMB and risk of overall, cardiovascular-related, and stroke-related 
mortality in an elderly population enriched for or at high risk for cardiovascular 
disease. Our findings indicate that the diagnosis of CMB is potentially of clinical 
relevance. Elderly people with CMB and additional cardiovascular risk factors 
could benefit from special cardiovascular monitoring to prevent death from 
cardiovascular complications. Larger studies are needed to expand our 
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The aim of this thesis was to investigate the radiological phenotype of the human 
brain in familial longevity with regard to brain structure. For this purpose, 
dedicated MR imaging techniques were applied to study the phenotype of the 
human brain on the macrostructural as well as microstructural level. To increase 
our insight in the aging process in general, potential modifying factors of age-
related structural brain changes such as coronary artery calcification and risk of 
mortality associated with cerebral microbleeds as an imaging correlate of cerebral 
small vessel disease were assessed. 
 
Chapter 2 aimed to identify whether the MRI phenotype of the brain in human 
longevity is marked by protection from age-related brain atrophy. Common age-
related loss of whole brain, cortical grey matter and white matter volume was 
found in the whole study population but no differences were observed between 
offspring and control subjects. However, left amygdalar volume was larger in 
offspring as compared to control subjects, whereas no association of left 
amygdalar volume was found with chronological age in both offspring and 
control subjects. Our findings suggest that at a mean age of 66 years human 
familial longevity is not marked by preserved whole brain, grey and white matter 
volumes. Furthermore, human familial longevity is characterized by a larger left 
amygdalar volume, most probably as a result of early development caused by a 
genetic familial trait. As amygdalar volumes are known to be lower in several 
neurodegenerative and neuropsychiatric diseases, we hypothesized that human 
familial longevity might be marked by a lower susceptibility to age-related brain 
damage. 
 
Hallmarks of cerebral small vessel disease, i.e. white matter lesions, lacunar 
infarcts and cerebral microbleeds were assessed (semi-)quantitatively in chapter 
3. Human familial longevity was associated with a lower susceptibility to 
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periventricular as well as subcortical white matter lesions and lacunar infarcts but 
not cerebral microbleeds. Interestingly, these associations were independent of 
the cardiovascular risk profile of the study population. These findings may imply 
that human familial longevity is marked by a genetically determined lower 
susceptibility to vascular brain damage in the course of aging which is not 
mediated by a genetically determined lower susceptibility to cardiovascular 
damage. 
 
Chapter 4 and 5 deal with the radiological phenotype of the brain in human 
longevity on the microstructural level. Using diffusion tensor imaging (DTI) 
white matter microstructural integrity was found to be preserved. By means of 
tract based spatial statistics (TBSS), a voxel-wise analysis approach of the spatial 
distribution of changes in white matter microstructure, human longevity was 
found to be characterized by preserved white matter integrity mainly in the genu 
and body of the corpus callosum. Moreover, we found a widespread age-related 
loss of white matter integrity with an anterior-posterior gradient, which has 
frequently been described in literature and lends support to a “last-in-first-out-
theory,” assuming that the predominantly frontally located late-myelinating 
regions, which consist of thinner myelinated axons, are more prone to age-related 
myelin breakdown. Bringing the results for chronological and biological aging 
together, we can conclude that human longevity is associated with preserved 
white matter microstructural integrity in regions which are especially prone to 
age-related damage. Taking the annual rate of change of white matter diffusion 
parameters into account, we could calculate a biological age benefit of 4.5 years 
with regard to white matter integrity for offspring with the propensity to become 
long-lived as compared to control subjects. These findings raised the question 
whether preserved white matter microstructure in human longevity could be 
explained by a lower susceptibility to age-related loss of myelin. For this purpose 
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magnetization transfer imaging (MTI) was performed. White matter MTI 
parameters were not different between offspring and control subjects, suggesting 
that preserved white matter integrity in human familial longevity is caused by a 
lower susceptibility to pathology other than demyelination. 
 
Coronary artery calcification was assessed as a potential modifying factor of age-
related vascular brain damage on the macro- and microstructural level in chapter 
6. Periventricular white matter lesions, lacunar infarcts and cerebral microbleeds 
but not brain atrophy were associated with coronary artery calcification. 
Moreover, loss of grey and white matter microstructural integrity was found with 
increasing coronary artery calcification predominantly in frontal/frontoparietal 
regions. The association of coronary artery calcification with focal ischemic 
lesions as well as widespread microstructural brain damage points to a 
generalized process equally affecting the heart and the brain. However, as 
described in chapter three, the genetically determined lower susceptibility to 
vascular brain damage is independent of a genetically determined lower 
susceptibility to cardiovascular damage 
 
In chapter 7 we found that hypertension-related nonlobar microbleeds were 
associated with an increased risk of cardiovascular mortality independent of 
cardiovascular risk factors. By contrast, cerebral amyloidy angiopathy (CAA) -
related lobar microbleeds were associated with an increased risk of stroke-related 
death. Additionally, number of microbleeds (more specifically presence of more 
than one microbleed) was associated with a considerably increased risk of stroke-
related mortality. Considering these findings, cerebral microbleeds are of 
potential clinical relevance and elderly individuals with cerebral microbleeds and 
cardiovascular risk factors could benefit from special cardiovascular 
monitoring/intervention to prevent death from cardiovascular complications. 
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The main purpose of this thesis was to analyse the phenotype of the brain in 
human familial longevity from a neuroimaging point of view. Several 
neuroimaging hallmarks of aging were less pronounced in subjects who are 
genetically enriched to become long-lived. 
Strikingly, human familial longevity was marked by a lower susceptibility to 
neuroimaging correlates of cerebral small vessel disease independent of 
traditional cardiovascular risk factors although these were also less distinct in the 
longevity phenotype. With the vast number of pathophysiological pathways of 
cerebral small vessel disease in mind (e.g. vascular risk factor-related, sporadic 
and hereditary CAA, genetic, inflammatory etc.) 162, we hypothesized that the 
lower susceptibility to white matter lesions in human familial longevity might not 
be driven by a lower susceptibility to cardiovascular damage but rather be 
determined by other not yet clearly identified mechanisms. Besides 
cardiovascular risk factors and genes, inflammatory markers have been shown to 
be associated with white matter lesions and it is known that lower systemic 
inflammation is associated with longevity in the elderly. Thus, lower systemic 
inflammation could be a possible explanation for the lower susceptibility to 
vascular brain damage in the sense of white matter lesions. 
Interestingly, white matter microstructural integrity was preserved in those 
regions which consist of late-myelinating thinner axons and are thought to be 
most prone to age-related deterioration according to the “last-in-first-out-theory”. 
However, longitudinal studies are needed to investigate whether other white 
matter regions are also preserved from age-related deterioration either because 
this part of the longevity phenotype becomes only obvious at a later stage in life 
or because effects are already present in other regions at this mean age but are too 
subtle to be picked up by MR imaging techniques. 
Using magnetization transfer imaging together with diffusion tensor imaging we 
could show that the preservation of white matter microstructural integrity cannot 
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be explained by a lower susceptibility to age-related demyelination but rather by 
a relatively lower decrease in axonal packing density through an increasing 
amount of extracellular water, which can be induced by different underlying 
pathological processes. Further studies are needed to disentangle the underlying 
histopathological substrate and its pathophysiological pathway. 
Larger amgdalar volume was associated with biological but not chronological 
aging and therefore most likely due to a genetic familial trait. As amygdalar 
volumes are known to be lower in several neurodegenerative and 
neuropsychiatric diseases, we hypothesized that human familial longevity might 
be marked by a lower susceptibility to age-related disorders. To disentangle the 
exact functional impact of this finding in human familial longevity however is a 
matter of further (functional) studies. 
 
Beyond focal ischemic lesions, coronary artery calcification, as an overall marker 
of atherosclerosis, was associated with widespread microstructural brain damage 
mainly paralleling the detrimental effects of the aging process on the heart and 
the brain. Thus, coronary artery calcification is not only a biomarker of 
cardiovascular disease but also of cerebrovascular damage. 
 
In elderly individuals with cardiovascular disease or an increased risk thereof, 
hypertension related nonlobar microbleeds were associated with an increased risk 
of cardiovascular death whereas cerebral amyloid angiopathy (CAA)-related 
lobar microbleeds were associated with an increased risk of stroke-related death. 
We conclude that elderly individuals with cerebral microbleeds and 
cardiovascular risk factors could benefit from special cardiovascular 
monitoring/intervention to prevent death from cardiovascular complications. 
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In conclusion, the structural phenotype of the brain in human familial longevity 
is considerably different from that of environmentally and age-matched control 
subjects. Both features which are most likely caused by early development and a 
lower susceptibility to known age-related structural brain changes on the macro- 
as well as microstructural level are hallmarks of the brain phenotype in longevity. 
However, one might also argue that the greater brain damage in the control group 
as compared to the offspring of long-lived families could contribute to an 
accelerated process of aging in “normally” aging people. The contributing 
mechanisms have yet to be identified but may involve homeostatic control and 
body function. Keeping in mind that there is a gradual transition from healthy or 
successful brain aging to what is generally accepted as “normal” brain aging and 
pathological brain changes as disease correlates, our study results implicate that 
the brains of offspring of nonagenarian siblings are less susceptible to 
neurodegenerative brain changes such as (vascular) dementia, Alzheimer’s 
disease and cerebrovascular disease. Our findings should be considered as 
starting points for future studies on the functional implications of the presented 
results and studies on the underlying pathways of brain structure preservation in 
human longevity to be able to translate the gained knowledge to health 
interventions for the general population to make elderly people in general live 
healthier for longer and to gain more insight in known pathological brain changes 
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Het doel van dit proefschrift was het in kaart brengen van de radiologische 
phenotype van het brein op structureel niveau in een studiepopulatie, die 
geselecteerd is op familiaire langlevendheid. Het onderzoek werd uitgevoerd in 
het kader van de Leiden Langleven Studie. In het kort werd deze studie opgezet 
om familiaire factoren voor langlevendheid te onderzoeken. De studiepopulatie, 
die in het kader van dit proefschrift werd onderzocht, bestaat uit kinderen van 
langlevende Nederlanders, die genetisch een verhoogde kans hebben zelf 
langlevend te worden en hun echtgenoten, die wat betreft hun leeftijd en 
omgevingsfactoren een ideale controle groep vormen. De gemiddelde leeftijd van 
alle studiedeelnemers was 66 jaar. Om de phenotype van het brein op zowel 
macro- als microstructureel niveau te kunnen bestuderen werden specifieke MRI 
(magnetization transfer imaging)-technieken gebruikt. Om het inzicht in het 
verouderingsprocess in het algemeen te vergroten, werden bovendien potentieel 
modificerende factoren van structurele veranderingen van het brein tijdens 
veroudering bestudeert. Voorbeelden hiervoor zijn verkalking van de coronairen 
en het risiko op sterfte dat verbonden is aan de diagnose van cerebrale 
microbloedingen, die wederom een beeldvormende afspiegeling van ziekte van 
de kleine bloedvaten in de hersenen zijn. 
 
In hoofdstuk 2 werd onderzocht of de MRI phenotype van het brein van mensen, 
die geselecteerd zijn op familiaire langlevendheid, gekenmerkt wordt door 
relatief minder volumeverlies. Wij vonden in de gehele studiepopulatie normaal 
leeftijds-gerelateerd verlies van het volume van het hele brein, de grijze en de 
witte stof. Echter konden er geen verschillen worden aangetoond tussen kinderen 
uit langlevende families en hun echtgenoten. Het volume van de linker amygdala 
van de kinderen uit langlevende families was groter vergeleken met de controle 
groep, maar was niet geassocieerd met leeftijd in de hele studiepopulatie. Uit deze 
bevindingen werd geconcludeerd dat familiaire langlevendheid op een 
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gemiddelde leeftijd van 66 jaar niet gekenmerkt wordt door minder volumeverlies 
van het hele brein, de grijze en witte stof. Familiaire langlevendheid wordt wel 
gekarakteriseerd door een groter volume van de linker amygdala, hetgeen meest 
waarschijnlijk ontstaat door familiaire aanleg in de vroege ontwikkelingsfase. Het 
is bekend dat een kleiner volume van de amygdalae geassocieerd is met 
verschillende neurodegeneratieve en neuropsychiatrische ziektes. Op basis 
hiervan werd de hypothese opgesteld dat lagere vatbaarheid voor ouderdoms-
gerelateerde brein schade in de zin van een relatief groter volume van de linker 
amygdala mogelijk een uiting is van familiaire langelevendheid. 
 
Verschillende beeldvormende kenmerken van ziekte van de kleine bloedvaten in 
het brein, zoals witte stof laesies, lacunaire infarcten en cerebrale 
microbloedingen, werden (semi-)quantitatief in hoofdstuk 3 onderzocht. 
Familiaire langlevendheid was geassocieerd met een lagere vatbaarheid voor 
periventriculaire en subcorticale witte stof laesies en lacunaire infarcten maar niet 
cerebrale microbloedingen. Interessant genoeg waren deze associaties 
onafhankelijk van het cardiovasculaire risikoprofiel van de studiepopulatie. Op 
basis van deze bevindingen werd de hypothese opgesteld dat de phenotype van 
familiaire langlevendheid gekenmerkt wordt door een genetisch bepaalde lagere 
vatbaarheid voor vasculaire brein schade tijdens het verouderingsprocess. Meest 
waarschijnlijk is dit niet op een genetisch bepaalde lagere vatbaarheid voor 
cardiovasculaire schade gebaseerd. 
 
In hoofdstuk 4 en 5 werd de radiologische phenotype van het brein in familiaire 
langlevendheid op microstructureel niveau onderzocht. Met behulp van diffusion 
tensor imaging (DTI) werd aangetoond dat de microstructurele integriteit van de 
witte stof in mensen, die geselecteerd zijn voor familiaire langlevendheid, hoger 
is vergeleken met de controle groep. Middels een voxel-based analyse-techniek 
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(tract based spatial statistics; TBSS) werd aangetoond dat de integriteit van de 
witte stof met name hoger is in de genu en corpus van het corpus callosum. 
Bovendien werd in de hele studiepopulatie een uitgebreid leeftijds-gerelateerd 
verlies van witte stof integriteit gevonden met een gradient van anterieure naar 
posterieure witte stof regio’s. Dit is al vaak in de literatuur beschreven en steunt 
de zogenoemde “last-in-first-out”-theory, die veronderstelt dat met name de 
frontaal gelocaliseerde witte stof gebieden, die uit dunnere axonen bestaan en pas 
laat in de ontwikkeling myeliniseren, vatbaarder zijn voor myeline schade in het 
kader van veroudering. Met het hoog op boven beschreven resultaten hebben wij 
geconcludeerd dat familiaire langlevendheid gekenmerkt wordt door betere 
integriteit van de witte stof met name in regio’s, die bijzonder vatbaar zijn voor 
schade tijdens het verouderingsprocess. Rekening houdend met de jaarlijkse 
verandering van witte stof diffusie parameters in de hele studiepopulatie, werd 
een biologisch leeftijdsvoordeel van 4,5 jaar berekend wat betreft de integriteit 
van de witte stof voor kinderen uit langlevende families vergeleken met hun 
echtgenoten. Op basis van deze bevindingen stelt zich de vraag of de beschreven 
betere integriteit van de witte stof in mensen, die geselecteerd zijn op familiaire 
langlevendheid, veroorzaakt wordt door een lagere vatbaarheid voor verlies van 
myeline tijdens het verouderingsprocess. Dit werd middels magnetization 
transfer imaging (MTI) nader onderzocht. MTI parameters van de witte stof 
waren niet verschillend tussen kinderen uit langlevende families en de controle 
groep. Dit suggereert dat de betere integriteit van de witte stof van kinderen uit 
langlevende families waarschijnlijk niet door een lagere vatbaarheid voor 
demyelinisatie maar andere pathologische processen in het brein tijdens de 
veroudering wordt veroorzaakt. 
 
Verkalking van de coronairen werd als een potentieel modificerende factor van 
leeftijds-gerelateerde vasculaire brein schade op macro- en microstructureel 
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niveau in hoofstuk 6 onderzocht. Periventriculaire witte stof laesies, lacunaire 
infarcten en cerebrale microbloedingen maar niet brein atrofie waren 
geassocieerd met verkalking van de coronairen. Bovendien naam de integriteit 
van de grijze en witte stof voornamelijk in frontale en frontoparietale brein 
regio’s met toenemende ernst van verkalking van de coronairen af. De associatie 
tussen verkalking van de coronairen en zowel focale ischemische laesies in het 
brein als uitgebreide schade op microstructureel niveau wijst op een 
gegeneraliseerd process, die in gelijke mate het hart en het brein aantast. Echter 
is, zoals in hoofdstuk 3 beschreven, de genetisch bepaalde lagere vatbaarheid 
voor vasculaire brein schade onafhankelijk van een genetisch bepaalde lagere 
vatbaarheid voor cardiovasculaire schade. 
 
In hoofdstuk 7 wordt beschreven dat niet-lobaire cerebrale microbloedingen, die 
gerelateerd zijn aan hypertensie met een verhoogd risico op cardiovasculaire 
mortaliteit geassocieerd zijn onafhankelijk van cardiovasculaire risiko factoren. 
Daarentegen zijn lobaire microbloedingen, die met name voorkomen in het kader 
van cerebrale amyloid angiopathie (CAA) geassocieerd met een verhoogd risiko 
op sterfte door stroke. Bovendien was het aantal microbloedingen - om precies te 
zijn de diagnose van meer dan één microbloeding - geassocieerd met een 
opmerkelijk verhoogd risiko op sterfte door stroke. Gezien deze bevindingen zijn 
cerebrale microbloedingen potentieel klinisch relevant en oudere mensen met 
cerebrale microbloedingen én cardiovasculaire risiko factoren zouden baat 
kunnen hebben bij speciale cardiovasculaire monitoring/interventies om sterfte 
door cardiovasculaire complicaties te voorkomen. 
 
Het doel van dit proefschrift was het in kaart brengen van de phenotype van het 
brein in familiaire langlevendheid vanuit het perspectief van neuroradiologische 
beeldvorming. Meerdere beeldvormende kenmerken van veroudering waren 
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minder uitgesproken in mensen, die genetisch op familiaire langlevendheid 
geselecteerd zijn. 
Het was een opmerkelijke bevinding dat familiaire langlevendheid gekenmerkt 
was door een lagere vatbaarheid voor beeldvormende afspiegelingen van ziekte 
van de kleine bloedvaten in het brein onafhankelijk van traditionele 
cardiovasculaire risiko factoren, alhoewel deze in de op familiaire langlevendheid 
geselecteerde groep eveneens minder uitgesproken waren. Met het oog op de 
grote hoeveelheid pathophysiologische pathways van de ziekte van de kleine 
bloedvaten in de hersenen (zoals bijvoorbeeld gerelateerd aan vasculaire risiko 
factoren, sporadisch en erfelijk CAA, genetisch, inflammatoir ezv.), hebben wij 
de hypothese opgesteld dat de lagere vatbaarheid voor witte stof laesies van 
mensen, die geselecteerd zijn op familiaire langlevendheid, mogelijk niet 
veroorzaakt wordt door een lagere vatbaarheid voor cardiovasculaire schade maar 
eerder bepaald wordt door andere nog niet goed gedefinieerde mechanismen. 
Naast cardiovasculaire risiko factoren en genen, is een associatie aagetoond 
tussen inflammatoire markers en langlevendheid bij oudere mensen. Derhalve 
zou een lager niveau van systemische inflammatie een mogelijke verklaring 
kunnen zijn voor de lagere vatbaarheid voor vasculaire brein schade in de zin van 
witte stof laesies bij mensen die geselecteerd zijn op familiaire langlevendheid. 
Interessant genoeg was de integriteit van de witte stof in gebieden hoger, die 
dunnere axonen bevatten en pas laat in de ontwikkeling myeliniseren en waarvan 
gedacht wordt dat ze het meest vatbaar zijn voor leeftijds-gerelateerde 
beschadiging volgens de “last-in-first-out”-theory. Er zijn echter longitudinale 
studies nodig om te onderzoeken of andere witte stof gebieden eveneens minder 
vatbaar zijn voor leeftijds-gerelateerde beschadiging of omdat dit gedeelte van de 
phenotype van langlevendheid pas in een later stadium duidelijk detecteerbaar 
wordt of omdat effecten in andere regio’s op deze gemiddelde leeftijd al aanwezig 
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maar te subtiel zijn om door beeldvormende (MRI) technieken al te kunnen 
worden opgespoord. 
Middels MTI en DTI hebben wij aangetoond dat de betere integriteit van de witte 
stof niet verklaard kon worden door een lagere vatbaarheid voor leeftijds-
gerelateerde demyelinisatie, maar eerder door een relatief geringere afname van 
de “axonal packing density” door een toenemende hoeveelheid extracellulair 
water, dat door verschillenden onderliggende pathologische processen kan 
worden veroorzaakt. Toekomstige studies moeten zich richten op het ontravelen 
van het onderliggende histopathologische substraat en de pathophysiologische 
pathway. 
Een groter volume van de linker amygdala was geassocieerd met biologische 
maar niet chronologische veroudering en daarom meest waarschijnlijk gebaseerd 
op familiaire aanleg. Het is bekend dat het volume van de amygdalae lager is bij 
meerdere neurodegeneratieve en neuropsychiatrische ziektes. Lagere vatbaarheid 
voor leeftijds-gerelateerde ziektes zou daarom een mogelijk kenmerk van de 
phenotype van langlevendheid kunnen zijn. Om het exacte functionele betekenis 
van onze bevinding te ontravelen zijn toekomstige (functionele) studies nodig. 
 
Verkalking van de coronairen als algemeen marker voor arterioslcerose was naast 
focale ischemische laesies ook geassocieerd met uigebreide brein schade op 
microstructureel niveau en loopt hierbij voor het overgrote deel gelijk aan de 
schadelijke effecten van het verouderingsprocess zelf op het hart en het brein. 
Derhalve kan verkalking van de coronairen niet alleen als biomarker voor 
cardiovasculaire ziekte maar ook voor cerbrovasculaire ziekte worden gezien. 
In een studiepopulatie bestaande uit mensen op oudere leeftijd met 
cardiovasculaire ziekte of een hoog risiko hierop waren hypertensie-gerelateerde 
niet-lobaire microbloedingen geassocieerd met een verhoogd risiko op 
cardiovasculaire sterfte, waartegen CAA-gerelateerde lobaire microbloedingen 
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met een verhoogd risiko op sterfte door stroke geassocieerd waren. Uit deze 
bevindingen concluderden wij dat oudere individuen met cerebrale 
mirobloedingen én cardiovasculaire risiko factoren profijt zouden kunnen trekken 
van speciaal cardiovasculair monitoring/interventies om sterfte door 
cardiovasculaire complicaties te voorkomen. 
 
Samenvattend kan worden vastgesteld dat de structurele phenotype van het brein 
in familiaire langlevendheid opmerkelijk anders is dan in de controle groep, die 
wat betreft leeftijd en omgevingsfactoren vergelijkbaar is. Zowel eigenschappen, 
die meest waarschijnlijk in de vroege ontwikkelingsfase door familiaire aanleg 
veroorzaakt worden als een lagere vatbaarheid voor bekende ouderdoms-
gerelateerde veranderingen van het brein op macro- en microstructureel niveau 
zijn kenmerken van het brein phenotype in familiaire langlevendheid. Anderzijds 
zou men kunnen argumenteren dat de grotere brein schade in de controle grope 
vergeleken met kinderen uit langlevende families een teken zou kunnen zijn van 
een versneld verouderingsprocess in “normaal” verouderende mensen. De 
hieraan bijdragende mechanismen moeten nog geidentificieerd worden maar 
zouden controle over de homeostase en lichamelijke functies kunnen omvatten. 
Onze bevindingen zouden als uitgangspunt voor toekomstige studies moeten 
worden gezien, die met name gericht zijn op de functionele implicaties en 
onderliggende mechanismen van de in dit proefschrift gepresenteerde resultaten. 
Hierdoor zou het mogelijk kunnen worden de verworven kennis naar interventies 
in de gezondheidszorg voor de algemene bevolking te vertalen om het mogelijk 
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Ziel der vorliegenden Dissertation war die Charakterisierung des radiologischen 
Phänotyps des Gehirns von Probanden mit familiärer Disposition zur Lang-
lebigkeit. Zur Beschreibung dieses Phänotyps auf sowohl makrostrukturellem als 
auch mikrostrukturellem Niveau wurden verschiedene Bildgebungstechniken, 
basierend auf der Kernspintomographie (Magnetresonanztomographie; MRT), 
angewendet. Um einen tieferen Einblick in den Alterungsprozess des mensch-
lichen Gehirns im Allgemeinen zu erhalten, wurde der Einfluss verschiedener, 
potentiell modifizierender Faktoren auf den Alterungsprozess untersucht, wie z. 
B. die Verkalkung der Koronaren und die mit zerebralen Mikroblutungen - als 
Bildgebungskorrelat der zerebralen Mikroangiopathie - verbundene Sterblich-
keit. 
 
In Kapitel 2 wird beschrieben, ob der mit Hilfe der MRT analysierte Phänotyp 
des Gehirns von Probanden mit familiärer Disposition zur Langlebigkeit durch 
ein relativ geringeres Ausmaß an Atrophie der Hirnsubstanz gekennzeichnet ist. 
Interessanterweise wurde die bekanntlich im Rahmen des normalen 
Alterungsprozesses auftretende Abnahme des Gesamtvolumens des Gehirns und 
des Volumens der kortikalen grauen und weißen Substanz in der gesamten 
Studienpopulation beobachtet. Ein Unterschied zwischen Probanden mit 
familiärer Disposition zur Langlebigkeit und Probanden der Kontrollgruppe war 
jedoch nicht nachweisbar. Das Volumen der linken Amygdala von Probanden mit 
familiärer Disposition zur Langlebigkeit war größer als dasjenige von Probanden 
der Kontrollgruppe, jedoch bemerkenswerterweise in beiden Gruppen nicht mit 
dem chronologischen Alter der Probanden assoziiert. Basierend auf diesen 
Ergebnissen wurde geschlussfolgert, dass im durchschnittlichen Alter von 66 
Jahren die familiäre Disposition zur Langlebigkeit (noch) keinen Einfluss hat auf 
die Volumina der gesamten Hirnsubstanz, der kortikalen grauen und weißen 
Substanz. Familiäre Langlebigkeit ist jedoch gekennzeichnet durch ein größeres 
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Volumen der linken Amygdala. Dies entsteht in Anbetracht unserer Ergebnisse 
wahrscheinlich schon in der frühen Entwicklungsphase als Folge familiärer 
genetische Prädisposition. Da bekanntlich einige neurodegenerative und neuro-
psychiatrische Erkrankungen durch ein kleineres Volumen der Amygdalae 
charakterisiert werden, lassen unsere Ergebnisse vermuten, dass familiäre Lang-
lebigkeit zu einem gewissen Grade vor altersbedingter Hirnschädigung schützt. 
 
Kapitel 3 vergleicht das Ausmaß der zerebralen Mikroangiopathie zwischen 
Probanden mit familiärer Disposition zur Langlebigkeit und Probanden der Kon-
trollgruppe. Dies geschieht durch semiquantitative Erfassung von u.a. Mark-
lagerläsionen, lakunären Infarkten und zerebralen Mikroblutungen. Familiäre 
Langlebigkeit war mit einer geringeren Anfälligkeit für sowohl periventrikuläre 
als auch subkortikale Marklagerläsionen und lakunäre Infarkte verbunden. Pro-
banden mit familiärer Disposition zur Langlebigkeit und Probanden der Kon-
trollgruppe hatten eine vergleichbare Anfälligkeit für zerebrale Mikroblutungen. 
Interessanterweise waren die beschriebenen Ergebnisse unabhängig vom 
kardiovaskulären Risikoprofil der Studienpopulation. Dies könnte bedeuten, dass 
familiäre Langlebigkeit durch eine genetisch bedingt niedrigere Anfälligkeit für 
altersbedingte vaskuläre Hirnschäden gekennzeichnet ist, die nicht durch eine ge-
netisch bedingt niedrigere Anfälligkeit für die Entwicklung kardiovaskulärer 
Risikofaktoren erklärbar ist. 
 
Kapitel 4 und 5 beschreiben den radiologischen Phänotyp des Gehirns von Pro-
banden mit familiärer Disposition zur Langlebigkeit auf mikrostrukturellem 
Niveau. Mit Hilfe von diffusionsgewichteten Aufnahmen (DTI, diffusion-
weighted imaging) konnte gezeigt werden, dass die mikrostrukturelle Integrität 
der weißen Substanz von Probanden mit familiärer Disposition zur Langlebigkeit 
höher ist als diejenige von Probanden der Kontrollgruppe. Die Verwendung von 
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tract-based spatial statistics (TBSS), einer Analysemethode, die auf Voxelniveau 
die Darstellung der räumlichen Verteilung mikrostruktureller Schäden der wei-
ßen Substanz ermöglicht, ergab, dass bei Probanden mit familiärer Disposition 
zur Langlebigkeit die mikrostrukturelle Unversehrtheit der weißen Substanz vor-
nehmlich im Corpus und Genu des Corpus callosum verglichen mit Probanden 
der Kontrollgruppe höher ist. Darüber hinaus wurde in der gesamten Stu-
dienpopulation ein ausgedehnter altersbedingter, von anterior nach posterior ab-
nehmender Verlust der mikrostrukturellen Integrität der weißen Substanz nach-
gewiesen. Dieses altersbedingte Phänomen wird in der Literatur häufig beschrie-
ben und unterstützt die sogenannte „Last-in-first-out“-Theorie, wonach ange-
nommen wird, dass die hauptsächlich frontal liegenden spät-myelinisierenden 
Regionen, die aus dünneren Axonen aufgebaut sind, anfälliger sind für alters-
bedingte Beschädigung des Myelins. In Anbetracht unserer Ergebnisse für den 
biologischen und chronologischen Alterungsprozess kann geschlussfolgert wer-
den, dass familiäre Langlebigkeit mit einer geringeren Anfälligkeit für mikro-
strukturelle Schäden der weißen Substanz assoziiert ist, und zwar vor allem in 
Gebieten, die sehr anfällig sind für altersbedingte mikrostrukturelle Schäden. 
Unter Berücksichtigung der jährlichen Änderungsrate der Diffusionsparameter 
betrug der biologische Altersvorteil von Probanden mit familiärer Disposition zur 
Langlebigkeit im Vergleich zu Probanden der Kontrollgruppe hinsichtlich der 
mikrostrukturellen Integrität der weißen Substanz ungefähr 4,5 Jahre. Diese 
Ergebnisse warfen die Frage auf, ob die relative mikrostrukturelle Unversehrtheit 
der weißen Substanz bei Probanden mit familiärer Disposition zur Langlebigkeit 
möglicherweise durch eine niedrigere Anfälligkeit für altersbedingten Verlust 
von Myelin erklärt werden könnte. Dies wurde mit Hilfe der Magnetisierungs-
Transfer-Bildgebung (MTI; magnetization transfer imaging) untersucht, wobei 
keine Unterschiede zwischen Probanden mit familiärer Disposition zur Lang-
lebigkeit und Probanden der Kontrollgruppe nachweisbar waren. Es ist somit 
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wahrscheinlich, dass die beschriebene relative mikrostrukturelle Unversehrtheit 
der weißen Substanz bei familiärer Disposition zur Langlebigkeit nicht durch eine 
niedrigere Anfälligkeit für altersbedingte Demyelinisierung verursacht wird. 
 
In Kapitel 6 wird die Verkalkung der Koronaren als potentiell modifizierender 
Faktor altersbedingter vaskulärer Hirnschädigung sowohl auf makro- als auch 
mikrostrukturellem Niveau untersucht. Im Gegensatz zur Hirnatrophie waren 
periventrikuläre Marklagerläsionen, lakunäre Infarkte und Mikroblutungen mit 
Verkalkung der Koronaren assoziiert. Außerdem nahm mit zunehmender Ver-
kalkung der Koronaren die mikrostrukturelle Integrität der weißen Substanz vor 
allem frontal und frontoparietal ab. Die beschriebene Verbindung zwischen Ko-
ronarverkalkung und sowohl fokalen ischämischen Hirnläsionen als auch aus-
gedehnter Schädigung auf mikrostrukturellem Niveau deutet auf einen gene-
ralisierten Prozess hin, der sich gleichermaßen auf Herz und Gehirn auswirkt. Die 
genetisch geringere Anfälligkeit für vaskuläre Hirnschädigung ist jedoch, wie in 
Kapitel 3 beschrieben, unabhängig von einer genetisch geringeren Anfälligkeit 
für kardiovaskuläre Risikofaktoren. 
 
Kapitel 7 beschreibt die Ergebnisse bezüglich der Anwesenheit zerebraler 
Mikroblutungen und des damit verbundenen Sterblichkeitsrisikos. Nicht-lobäre 
Mikroblutungen waren mit einem erhöhten kardiovaskulären Mortalitätsrisiko 
verbunden, unabhängig von kardiovaskulären Risikofaktoren. Im Gegensatz dazu 
waren die durch zerebrale Amyloidangiopathie (cerebral amyloid angiopathy; 
CAA) bedingten lobären Mikroblutungen mit einem erhöhten Sterb-
lichkeitsrisiko durch Schlaganfall assoziiert. Unsere Ergebnisse deuten darauf 
hin, dass zerebrale Mikroblutungen potentiell klinisch relevant sind und dass 
ältere Menschen mit zerebralen Mikroblutungen und zusätzlichen 
kardiovaskulären Risikofaktoren von speziellem kardiovaskulären Monitoring 
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profitieren könnten hinsichtlich einer Senkung der Sterblichkeit durch kar-
diovaskuläre Ursachen. 
 
Das Hauptthema dieser Dissertation war die Beschreibung des Phänotyps des 
menschlichen Gehirns von Probanden mit familiärer Disposition zur Langle-
bigkeit aus der Bildgebungsperspektive. Mehrere Bildgebungskennzeichen der 
Hirnalterung waren bei Probanden mit familiärer Disposition zur Langlebigkeit 
weniger ausgeprägt als bei Probanden der Kontrollgruppe. 
Bemerkenswerterweise war familiäre Langlebigkeit gekennzeichnet durch eine 
geringere Anfälligkeit für Bildgebungskorrelate der zerebralen Mikroangiopathie 
unabhängig von traditionellen kardiovaskulären Risikofaktoren, obwohl diese im 
Langlebigkeits-Phänotyp weniger ausgeprägt waren. Vor dem Hintergrund der 
großen Zahl pathophysiologischer Erklärungsmechanismen (wie z. B. bedingt 
durch vaskuläre Risikofaktoren, sporadisch, erblich (CAA), genetisch oder ent-
zündlich), wurde die Hypothese aufgestellt, dass die geringere Anfälligkeit für 
Marklagerläsionen von Probanden mit familiärer Disposition zur Langlebigkeit 
wahrscheinlich nicht durch eine geringere Anfälligkeit für kardiovaskuläre Ri-
sikofaktoren sondern eher durch noch nicht näher definierte Mechanismen be-
dingt wird. Außer kardiovaskulären Risikofaktoren und Genen sind auch Ent-
zündungsmarker mit dem Auftreten von Marklagerläsionen assoziiert. Außerdem 
ist bekannt, dass ein niedrigeres systemisches Entzündungsniveau mit 
Langlebigkeit assoziiert ist. Darum könnte ein niedrigeres systemisches Ent-
zündungsniveau eine mögliche Erklärung sein für die geringere Anfälligkeit für 
vaskuläre Hirnschädigung in Form von Marklagerläsionen. 
Interessanterweise war die mikrostrukturelle Integrität der weißen Substanz in 
denjenigen Regionen höher, die aus spät-myelinisierenden Axonen bestehen und 
von denen man annimmt, dass sie am anfälligsten sind für altersbedingte Schä-
digung im Sinne der „Last-in-first-out“-Theorie. Es sind jedoch longitudinale 
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Studien notwendig, um zu untersuchen, ob auch andere Regionen der weißen 
Subs-tanz gegenüber dem Alterungsprozess geschützt sind, entweder weil dieser 
Teil des Phänotyps der Langlebigkeit sich erst später manifestiert oder weil die 
Unterschiede zu anderen Hirnregionen in diesem Alter noch zu subtil sind, um 
mit den beschriebenen Bildgebungsmethoden entdeckt werden zu können. 
 
Unter Verwendung von MTI zusammen mit DTI wurde beschrieben, dass die re-
lative mikrostrukturelle Unversehrtheit bestimmter Regionen der weißen Subs-
tanz nicht durch eine geringere Anfälligkeit für altersbedingte Demyelinisierung 
erklärt werden kann, sondern eher durch eine relativ geringere Abnahme der 
Dichte der Axone durch Zunahme der extrazellulären Flüssigkeit, die wiederum 
durch unterschiedliche pathologische Prozesse hervorgerufen werden kann. Das 
zugrundeliegende histopathologische Substrat und die zugehörigen patho-
physiologischen Mechanismen bleiben zukünftigen Studien vorbehalten. 
Familiäre Langlebigkeit war gekennzeichnet durch ein größeres Volumen der 
linken Amygdala. Das Fehlen einer Assoziation mit dem chronologischen Alter 
der Probanden legt nahe, dass dieses Merkmal schon in der frühen Ent-
wicklungsphase als Folge familiärer genetischer Prädisposition entsteht. Da das 
Volumen der Amygdalae bekanntlich bei mehreren neurodegenerativen und 
neuropsychiatrischen Krankheiten vermindert ist, wurde die Hypothese auf-
gestellt, dass familiäre Langlebigkeit möglicherweise durch eine geringere Anfäl-
ligkeit für diese Krankheiten gekennzeichnet ist. Zukünftige (funktionelle) Stu-
dien müssen jedoch die genaue funktionelle Bedeutung dieser Ergebnisse klären. 
 
Die Verkalkung der Koronaren war als allgemeiner Marker für Arteriosklerose 
neben fokalen ischämischen Läsionen auch mit ausgedehnten Hirnschädigungen 
auf mikrostrukturellem Niveau assoziiert und läuft hiermit parallel zu den Schä-
digungen des Gehirns durch den Alterungsprozess selbst. Die Verkalkung der 
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Koronaren ist daher nicht nur ein Biomarker für kardiovaskuläre Erkrankungen, 
sondern auch für zerebrovaskuläre Schäden. 
 
Bei älteren Menschen mit Prädisposition zu oder manifester kardiovaskulärer 
Erkrankung waren nicht-lobäre Mikroblutungen mit einer erhöhten kardiovas-
kulären Sterblichkeit verbunden, während CAA-bedingte Mikroblutungen mit 
einer erhöhten Sterblichkeit durch Schlaganfall assoziiert waren. Ältere Men-
schen mit sowohl zerebralen Mikroblutungen als auch kardiovaskulären Ri-
sikofaktoren könnten daher zur Senkung der kardiovaskulären Sterblichkeit von 
zusätzlichem kardiovaskulären Monitoring profitieren. 
 
Zusammenfassend kann festgestellt werden, dass sich der strukturelle Phänotyp 
des Gehirns von Probanden mit familiärer Disposition zur Langlebigkeit beacht-
lich von demjenigen der, Umweltfaktoren und Alter betreffend vergleichbaren, 
Kontrollgruppe unterscheidet. Sowohl Merkmale, die sehr wahrscheinlich als 
Folge familiärer genetischer Prädisposition entstehen als auch eine geringere An-
fälligkeit für bekannte altersbedingte strukturelle Hirnschäden auf sowohl makro- 
als auch mikrostrukturellem Niveau kennzeichnen den Phänotyp des Gehirns von 
Probanden mit familiärer Disposition zur Langlebigkeit. Man könnte jedoch auch 
argumentieren, dass die größere Hirnschädigung in der Kontrollgruppe zu einem 
schnelleren Alterungsprozess „normal“ alternder Menschen führt. Die zugrunde-
liegenden Mechanismen müssen noch identifiziert werden, könnten aber u.a. 
Homöostase und Körperfunktion beinhalten. Angesichts der Tatsache, dass der 
Übergang von gesundem/erfolgreichem Altern (healthy/successful aging) zu 
„normalem“ Altern und pathologischen Veränderungen des Gehirns als Zeichen 
von Krankheit fließend ist, suggerieren die Ergebnisse dieser Studie, dass die Ge-
hirne von Probanden mit familiärer Disposition zur Langlebigkeit weniger anfäl-
lig sind für neurodegenerative Veränderungen wie (vaskuläre) Demenz, Morbus 
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Alzheimer und zerebrovaskuläre Erkrankungen. Die im Rahmen dieser Disser-
tation beschriebenen Ergebnisse sollten als Ausgangspunkt für zukünftige Stu-
dien dienen, die sowohl die funktionellen Folgen als auch zugrundeliegenden 
Mechanismen untersuchen. Erst dann können die hier gewonnenen Erkenntnisse 
auf eine Weise in die klinische Praxis umgesetzt werden, die es der allgemeinen 
Bevölkerung ermöglicht, länger gesünder zu leben, und können bekannte patho-
logische Veränderungen während des Alterungsprozesses wie z.B. Morbus Alz-
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